taVNS: A Complete Guide to Transcutaneous Auricular Vagus Nerve Stimulation

taVNS: A Complete Guide to Transcutaneous Auricular Vagus Nerve Stimulation

There has been a noticeable shift in the way people talk about the nervous system.

A few years ago, most of the people I worked with had never heard the term nervous system regulation.

Today, many arrive already knowing the language.

They talk about the vagus nerve.

Polyvagal Theory.

Fight or flight.

Freeze.

Heart-rate variability.

Breathwork.

Somatic work.

They may have tried meditation, yoga, cold exposure, supplements, breathing exercises and a growing list of techniques designed to somehow “reset” their nervous system.

And increasingly, I am being asked about something else.

taVNS.

Transcutaneous auricular vagus nerve stimulation.

It sounds complicated.

In practical terms, taVNS involves applying a mild electrical stimulus to specific areas of the outer ear that receive sensory innervation associated with the auricular branch of the vagus nerve.

No surgery.

No implanted device.

No attempt to electrically stimulate the vagus nerve through the neck.

The stimulation is delivered through the ear.

That relative simplicity is one reason interest in taVNS has grown so quickly.

But there is also a problem.

Whenever a new nervous-system intervention becomes popular, the claims tend to travel faster than the science.

Suddenly something is described as:

A nervous system reset.

A trauma cure.

A vagus nerve hack.

A treatment for anxiety, depression, burnout, insomnia, inflammation, PTSD and almost everything else.

That is not how I think we should talk about taVNS.

I am interested in it precisely because I think it deserves a more serious conversation.

There is a growing research literature around transcutaneous auricular vagus nerve stimulation. A 2024 clinical scoping review identified 109 studies across 21 clinical populations, while also highlighting something that matters enormously: stimulation parameters remain inconsistent and the field still needs better standardisation.

A more recent review likewise found taVNS to be generally well tolerated while emphasising that results can depend considerably on how stimulation is delivered and that further validation is still needed.

In other words:

There is enough here to take seriously.

There is not enough here to pretend every question has already been answered.

That distinction will run through this entire guide.

Because I do not believe nervous system work gains credibility by exaggerating what we know.

Quite the opposite.

At Pesona Jiwa, we integrate taVNS into our nervous-system work and into our dedicated 28-Day taVNS Intensive Healing Retreat. Guests use Zenowell technology as part of a much broader programme involving psychotherapy, nervous system education, regulation work, movement, rest and a private therapeutic environment. Explore the 28-Day taVNS Intensive Healing Retreat

But I want to be clear from the beginning.

The device is not the programme.

taVNS does not replace psychotherapy.

It does not make sleep irrelevant.

It does not remove the need for boundaries.

It cannot make an unsustainable working environment sustainable.

And I would never describe it as a standalone cure for trauma.

What interests me is something more nuanced.

Can a physiological intervention help create conditions in which some people become more able to regulate?

More able to remain present?

More able to engage in therapeutic work?

Less overwhelmed by internal activation?

Better able to notice what their nervous system is doing without immediately being carried away by it?

Those are much more interesting questions.

And they are where I believe taVNS belongs.

What Does taVNS Actually Stand For?

taVNS stands for transcutaneous auricular vagus nerve stimulation.

Breaking that down makes it much easier to understand.

Transcutaneous means stimulation is delivered through the skin.

Auricular refers to the ear.

Vagus nerve stimulation refers to the intention to influence vagal pathways through electrical stimulation.

So rather than surgically implanting a device around the cervical vagus nerve—as occurs with traditional implanted vagus nerve stimulation—taVNS uses electrodes placed on particular areas of the external ear.

That difference is important.

Traditional implanted vagus nerve stimulation has established clinical uses and involves a surgical procedure.

taVNS is non-invasive.

The person wears an external device.

That makes it far more accessible for research and for applications in which surgery would clearly be inappropriate.

But accessibility should not be confused with simplicity.

Where the electrodes are placed matters.

The stimulation parameters matter.

Intensity matters.

Frequency matters.

Duration matters.

The individual matters.

This is one of the reasons I am cautious whenever taVNS is marketed as though attaching a device to your ear automatically equals “vagus nerve activation.”

The research field itself continues to debate optimal protocols.

The 2024 clinical scoping review found substantial variability in stimulation parameters across studies, while a 2025 review again highlighted inconsistency in both parameters and reported effects.

So one of the first things to understand about taVNS is:

taVNS is not one single standardised intervention.

Different studies may use different ear locations.

Different frequencies.

Different pulse widths.

Different session lengths.

Different treatment schedules.

That makes reading headlines about “taVNS works” or “taVNS does not work” far less straightforward than it appears.

You have to ask:

For what?

In whom?

Using what protocol?

For how long?

Compared with what?

Those are the questions that matter.

Why the Ear?

This is usually the next question.

If the vagus nerve travels from the brainstem through the neck and into the chest and abdomen, why would we stimulate the ear?

Because the external ear contains sensory innervation associated with the auricular branch of the vagus nerve.

Researchers have therefore investigated whether stimulating appropriate auricular regions can influence vagal afferent pathways without requiring an implanted cervical device.

In simple terms, much of the vagus nerve’s communication is afferent.

Information is travelling towards the brain.

This is important because popular descriptions often portray the vagus nerve as little more than a “calming nerve” running from the brain down into the body.

That is much too simplistic.

The vagus nerve is part of a complex communication network connecting the brain and multiple bodily systems.

taVNS attempts to access part of that network through the sensory pathways available in the ear.

Research reviews describe taVNS as a non-invasive neuromodulation approach capable of influencing neural networks involving the brain, brainstem and autonomic nervous system, although exactly how these effects translate into clinical outcomes remains an active area of investigation.

That word—neuromodulation—is useful.

Because we are not simply trying to “turn on calm.”

We are attempting to influence activity within neural systems.

And neural systems are complicated.

The Vagus Nerve Is Not an On-Off Switch for Calm

This is probably worth saying early.

The vagus nerve has become one of the most oversimplified structures in modern wellness.

Scroll through social media and you could easily believe that every emotional difficulty comes from a poorly functioning vagus nerve and that humming, gargling, cold water or electrical stimulation can simply switch the parasympathetic nervous system back on.

Human physiology does not work like that.

The autonomic nervous system is dynamic.

Context dependent.

Responsive to the body, brain, environment, relationships and perceived demands.

The vagus nerve is important within that system.

It is not the whole system.

This matters because people often arrive looking for a way to make their nervous system behave.

They want to switch off fight or flight.

Increase vagal tone.

Become parasympathetic.

Stay calm.

But as I have written in How to Regulate Your Nervous System (What Actually Works), the goal of regulation is not permanent calm.

The goal is capacity.

The ability to mobilise when life requires action.

And then recover.

The ability to experience stress without remaining trapped in stress.

The ability to move between states rather than becoming chronically stuck in one.

That is how I think about taVNS as well.

Not:

“How do we electrically force someone to become calm?”

But:

“Can this become one useful input within a wider process of restoring nervous system flexibility?”

That is a very different proposition.

What Is Vagus Nerve Stimulation?

To understand taVNS properly, it helps to separate it from traditional vagus nerve stimulation.

Implanted vagus nerve stimulation, usually referred to simply as VNS, involves surgically implanting a pulse generator and connecting it to the vagus nerve in the neck.

This is not a wellness treatment.

It is a medical neuromodulation procedure with established applications, including certain cases of epilepsy and treatment-resistant depression.

taVNS approaches the system differently.

Rather than surgery, electrical stimulation is delivered transcutaneously through the ear.

That creates several obvious advantages.

It is non-invasive.

It does not require an implanted pulse generator.

It is easier to administer repeatedly.

It is therefore much easier to investigate across different populations.

But again, the fact that it is less invasive does not mean we should simply transfer every claim made about implanted VNS to taVNS.

They are not identical interventions.

The stimulation site is different.

The way stimulation reaches vagal pathways is different.

The evidence bases are different.

That distinction is often lost online.

What Is Neuromodulation?

Neuromodulation sounds highly technical.

At its simplest, it means influencing the activity of the nervous system.

Different neuromodulation methods do this in very different ways.

Some are invasive.

Some non-invasive.

Some use electrical stimulation.

Others use magnetic stimulation.

What makes taVNS interesting is the possibility of influencing nervous-system activity through a relatively accessible peripheral route.

Researchers have investigated taVNS across psychiatric, neurological, cardiovascular, pain and other clinical areas. The 2024 scoping review found studies spanning 21 clinical populations, while also concluding that parameter reporting and standardisation remain major limitations.

This broad research interest is exciting.

It is also exactly why caution matters.

When an intervention is being studied across many conditions, it is very easy for:

“Researchers are investigating this”

to become:

“This treats all of these conditions.”

Those statements are not equivalent.

Throughout this guide, I will repeatedly separate:

What has been established.

What appears promising.

What remains uncertain.

And what I have observed in my own clinical work.

I think readers deserve that distinction.

Is taVNS New?

Not entirely.

Vagus nerve stimulation has a longer history within medical neuromodulation.

What is comparatively newer is the rapidly expanding investigation of non-invasive approaches such as taVNS.

The research base has grown substantially.

And as often happens, commercial interest has grown alongside it.

That creates both opportunity and risk.

The opportunity is obvious.

If researchers can better understand how to influence relevant vagal pathways non-invasively, there may be meaningful applications.

The risk is that commercial language moves ahead of clinical evidence.

Terms like:

“reset your nervous system”

“heal your vagus nerve”

“rewire trauma”

sound compelling.

They also create expectations the science may not currently justify.

I would rather say:

taVNS is a promising non-invasive neuromodulation approach with a growing evidence base, but questions remain around optimal parameters, mechanisms, individual response and condition-specific efficacy.

That sounds less spectacular.

It is also much closer to where the research actually stands.

Is taVNS Safe?

Overall, the published safety picture is encouraging.

A systematic review and meta-analysis examining 177 studies involving more than 6,000 participants found no evidence of a causal relationship between taVNS and severe adverse events in the included literature. Commonly reported effects included ear discomfort or pain, headache and tingling. The authors nevertheless highlighted inconsistent adverse-event reporting across studies.

A more recent 2025 review similarly described taVNS as relatively safe, with minor adverse effects reported and no serious adverse events attributed to the stimulation parameters considered in that review. It also called for better safety reporting and greater standardisation.

That is reassuring.

But “generally well tolerated in research” does not mean:

“Everyone should buy a device and experiment without guidance.”

Safety also involves appropriate screening.

Correct use.

Appropriate placement.

Appropriate stimulation intensity.

Understanding the person’s health history.

Knowing when to stop.

Knowing when an intervention simply is not appropriate.

We will explore contraindications and safety in much greater detail later in this guide.

What Does taVNS Feel Like?

This is one of the most practical questions people ask me.

Usually, the stimulation itself is not dramatic.

Depending on the device, placement and intensity, people may notice a mild tingling or electrical sensation around the ear.

For many, it becomes relatively unobtrusive.

But there is no prize for turning the intensity as high as possible.

More sensation does not automatically mean more benefit.

That is another place where the “push harder” mentality can enter nervous-system work.

Many of the people I work with are already very good at pushing.

They do not need another intervention to turn into an endurance exercise.

The aim is appropriate stimulation.

Not proving how much stimulation you can tolerate.

What Do We Notice Clinically?

This is where I need to separate my own observations from published evidence.

In our work at Pesona Jiwa, some people describe feeling calmer or more grounded following taVNS.

Others describe less internal agitation.

Some find it easier to sit within psychotherapy without feeling quite as physiologically overwhelmed.

Others notice improved sleep or a greater sense of emotional availability.

These are clinical observations and subjective reports.

They are not proof that taVNS will produce those responses for every person.

That distinction matters to me.

Because the moment we turn clinical observation into universal promise, we stop being clinically honest.

What interests me is not whether everyone says:

“I feel calm.”

What interests me is whether the intervention appears to support the wider therapeutic process for the individual in front of us.

Can they stay present for longer?

Can they notice sensations without immediately becoming overwhelmed?

Does their recovery after activation change?

Do they sleep differently?

Does psychotherapy become more accessible?

That is where I see the value of integrating taVNS rather than treating it as an isolated treatment.

Why We Integrate taVNS Rather Than Use It Alone

At Pesona Jiwa, our wider approach is based around the idea that the nervous system is continually learning from experience.

Therapy is an experience.

Relationships are experiences.

The physical environment is an experience.

Sleep is an experience.

Having your needs responded to consistently is an experience.

Setting a boundary and discovering that the world does not collapse is an experience.

taVNS is another input into that system.

It does not replace the others.

This is particularly relevant to our work around trauma and chronic stress.

Someone may intellectually understand that they are safe while their body continues reacting as though the past is still present.

That is one of the themes explored in our article Healing Trauma Through the Nervous System at Pesona Jiwa Retreats.

Our Polyvagal-informed approach is interested in that gap between intellectual understanding and physiological experience.

And this is where taVNS becomes clinically interesting to me.

Not because a device can teach somebody that their childhood is over.

It cannot.

Not because electricity can process grief.

It cannot.

Not because stimulating the ear resolves attachment wounds.

It does not.

But if physiological support helps somebody remain more present while those experiences are explored, that may have value.

That is the integration I am interested in.

Where Zenowell Fits Into Our Work at Pesona Jiwa

Within our 28-Day taVNS Intensive Healing Retreat, we currently use Zenowell technology as part of the nervous-system programme.

The guest does not simply arrive, receive a device and disappear for 28 days.

The technology sits within a private therapeutic environment.

Psychotherapy.

Daily nervous-system work.

Movement.

Meditative practice.

Bodywork.

Rest.

Nutrition.

Sleep.

Nature.

And the experience of stepping away from the roles and demands that may have kept the nervous system chronically activated.

The guest receives a Zenowell device to use during the programme and continue using after returning home.

This is important because I do not see taVNS as something separate from the rest of recovery.

It is one component.

And perhaps more importantly, it gives us an opportunity to help people understand their nervous system while they are using it.

Why am I activated?

What happens when I stop?

What does safety actually feel like for me?

What keeps pulling me back into vigilance?

Where do I override my limits?

What happens when someone else takes care of me?

These are psychotherapy questions.

Not device questions.

That difference is fundamental to the way we integrate the technology.

The Question Is Bigger Than “Does taVNS Work?”

People understandably want a simple answer.

Does taVNS work?

But I think we need to ask a better series of questions.

Works for what?

For whom?

Measured how?

Using which stimulation parameters?

For what duration?

As a standalone intervention or alongside another treatment?

And what does “work” actually mean?

Reduced symptoms?

Improved sleep?

Changes in autonomic measures?

Greater emotional regulation?

A greater ability to participate in psychotherapy?

Those distinctions matter.

The current literature is encouraging enough that taVNS deserves serious attention, while heterogeneous protocols and inconsistent reporting remain major limitations across the field.

That is where I want to begin this guide.

Not by selling certainty.

By understanding the intervention properly.

Because if taVNS is going to become part of modern nervous-system care, we need to move beyond both extremes.

It is not a miracle device.

It is not meaningless technology.

It is an emerging neuromodulation approach with a growing research base and some genuinely interesting possibilities.

The next question is:

What is actually happening between the ear, the vagus nerve and the brain when we use it?

And that is where we go next.

How Does taVNS Actually Work?

This is where the conversation gets more interesting.

And more complicated.

Because once we move beyond the phrase “vagus nerve stimulation,” we have to talk about anatomy.

What exactly are we stimulating?

Where does that information travel?

What happens when it reaches the brain?

And how much of what people say online is actually supported by evidence?

The first thing to understand is that the vagus nerve is not simply one long calming wire running from the brain to the body.

It is a complex cranial nerve involved in communication between the brainstem and multiple organs.

It carries information in both directions.

And importantly, a large proportion of vagal fibres are afferent.

That means information is travelling from the body towards the brain.

This is one of the reasons taVNS has become so interesting.

We are not simply attempting to send a “relax” command downwards.

We are stimulating a sensory pathway that may influence wider neural systems involved in autonomic regulation, arousal, attention, emotion and recovery.

That does not mean every downstream effect is fully understood.

It means the biology is more interesting than the marketing version.

The Vagus Nerve Is Cranial Nerve X

The vagus nerve is the tenth cranial nerve.

It emerges from the brainstem and travels through the neck before extending into the chest and abdomen.

It contributes to communication involving structures including the:

• heart
• lungs
• pharynx
• larynx
• gastrointestinal system
• several visceral organs

This enormous distribution is why the vagus nerve has attracted so much scientific interest.

But it is also why claims about it need to be careful.

The vagus nerve participates in many functions.

That does not mean stimulating one part of it automatically treats every process with which it is associated.

A recent review describes the vagus nerve as predominantly afferent, with sensory information travelling towards the brainstem as part of this wider brain-body communication network.

That afferent component is particularly relevant to taVNS.

What Is the Auricular Branch of the Vagus Nerve?

The auricular branch of the vagus nerve, usually abbreviated to ABVN, is a small sensory branch associated with parts of the external ear.

It is sometimes called Arnold’s nerve.

This branch is what makes auricular stimulation possible.

Unlike implanted cervical VNS, taVNS is not attempting to directly stimulate the main vagal trunk in the neck.

Instead, electrodes are placed on particular parts of the ear where sensory innervation from the ABVN is believed to be accessible through the skin.

That sounds straightforward.

In practice, the anatomy is more complicated.

The ear is not supplied exclusively by the vagus nerve.

It also receives sensory innervation from other nerves, including branches associated with the trigeminal system and cervical spinal nerves.

This matters because putting an electrode anywhere on the ear does not automatically mean you are selectively stimulating vagal fibres.

The external ear contains overlapping innervation.

Research reviews continue to note uncertainty around the precise cutaneous distribution of the ABVN and which auricular target is optimal.

That is one reason electrode placement matters.

Where on the Ear Is taVNS Usually Applied?

Two areas appear repeatedly in the research:

the tragus

and

the cymba conchae.

The tragus is the small projection of cartilage in front of the ear canal.

The cymba conchae is part of the upper conchal region of the external ear.

Both have been used in human taVNS research.

Some anatomical and neuroimaging evidence suggests the cymba conchae may provide particularly strong access to vagal afferent pathways, while tragus stimulation has also produced evidence of target engagement. Reviews therefore tend to regard both the inner tragus and conchal regions as plausible stimulation sites rather than presenting one universally accepted location.

That uncertainty is worth preserving.

Because one of the recurring problems in emerging technologies is false precision.

People want one perfect answer.

Put the electrode exactly here.

Use exactly this frequency.

Stimulate for exactly this long.

Then the nervous system will respond.

The science is not there yet.

There is substantial heterogeneity between protocols.

Different studies use different anatomical locations, stimulation intensities, pulse widths, frequencies and session durations.

So when someone asks me:

“What is the best taVNS protocol?”

my answer is not:

“We know exactly.”

We do not.

The field is still refining that question.

Why Stimulation Location Matters

Electrical stimulation does not know which nerve you intended to stimulate.

Current spreads through tissue.

The anatomical target matters.

Electrode size matters.

Contact quality matters.

Placement matters.

Intensity matters.

If stimulation is poorly positioned, neighbouring sensory nerves may be recruited.

That does not necessarily make the stimulation meaningless.

But it complicates the assumption that every effect observed is specifically vagal.

This is one of the reasons researchers use control or sham sites.

The earlobe, for example, has often been used as a comparison site because it is generally considered less strongly associated with ABVN innervation.

But even sham design is not simple.

Some supposedly inactive control sites may still produce sensory input.

So even apparently straightforward taVNS trials can contain methodological challenges.

That is why I am cautious about single studies.

I am far more interested in patterns emerging across multiple trials and reviews.

What Happens After the Ear Is Stimulated?

The proposed pathway begins with sensory fibres in the auricular branch of the vagus nerve.

These signals travel towards the brainstem.

One of the most important structures discussed in this pathway is the nucleus tractus solitarius, often abbreviated to NTS.

This is a brainstem region involved in receiving visceral sensory information.

From there, networks extend more widely.

This is where taVNS begins to become much more interesting than the phrase “stimulate the vagus nerve” suggests.

Because once afferent information reaches the brainstem, downstream signalling may interact with broader systems involved in:

• autonomic regulation
• arousal
• attention
• mood
• sensory processing
• pain
• emotional responses

Neuroimaging studies have reported changes in brainstem and higher brain regions following auricular stimulation, including areas associated with the NTS, locus coeruleus and broader cortical and limbic networks.

But results differ across studies.

That variability is important.

A review of the anatomical and imaging evidence found considerable heterogeneity in the brain regions activated by taVNS and noted that stimulation location and parameters may contribute to these differences.

So I would not say:

“taVNS stimulates the ear and then activates exactly this sequence of brain regions every time.”

A more accurate description is:

Auricular stimulation appears capable of engaging vagal afferent pathways and influencing distributed neural networks, but the exact pattern depends on multiple variables and remains an active area of research.

That is less convenient.

It is also more honest.

What Is the Nucleus Tractus Solitarius?

The nucleus tractus solitarius sits within the medulla of the brainstem.

It acts as an important processing centre for sensory information arriving from several cranial nerves, including the vagus nerve.

You could think of it as one part of the system through which information about internal bodily state reaches the central nervous system.

It does not function in isolation.

It communicates with numerous other regions.

That broader connectivity is important when discussing taVNS.

Because the potential effects are unlikely to come from one structure alone.

Researchers are studying networks.

Not one switch.

This is another reason simplistic explanations like:

“taVNS activates your parasympathetic nervous system”

do not really capture what may be happening.

The reality is more distributed.

The Locus Coeruleus

Another brainstem structure commonly discussed in taVNS research is the locus coeruleus.

The locus coeruleus is strongly associated with noradrenergic signalling and plays important roles in arousal, attention, vigilance and adaptive responses to changing environments.

At first glance, that may sound surprising.

If taVNS is supposed to be “calming,” why would we be interested in a system associated with arousal and attention?

Because healthy regulation is not simply reduced arousal.

It is appropriate arousal.

This goes back to the distinction I make repeatedly in our nervous-system work.

The goal is not to become permanently parasympathetic.

The goal is flexibility.

There are times we need to be alert.

Focused.

Mobilised.

Responsive.

There are other times we need to recover.

A healthy nervous system can do both.

Some imaging studies suggest auricular stimulation can influence brainstem pathways involving both the NTS and locus coeruleus.

That fits much better with a model of modulation than a model of simply “switching on calm.”

Why I Prefer the Word Modulation

This is why I prefer talking about neuromodulation.

The word regulation is useful.

But in popular culture it has increasingly become synonymous with making the nervous system quiet.

Neuromodulation is a little more accurate.

It describes influencing patterns of neural activity.

Not forcing one permanent state.

That is potentially relevant to people who experience very different forms of dysregulation.

One person may be chronically anxious and activated.

Another may feel exhausted and shut down.

Another may alternate between both.

If our model is simply:

“More vagus equals calmer,”

we miss the complexity of these presentations.

The Brain Does Not Operate Separately From the Body

One of the things I appreciate about nervous-system work is that it challenges the artificial division between psychological and physical experience.

People often talk about mental health as though it happens entirely inside the mind.

Thoughts.

Beliefs.

Memories.

Emotions.

But every emotion has a bodily component.

Fear changes breathing.

Anger changes muscle tone.

Anxiety changes heart rate and attention.

Shame can alter posture and eye contact.

Connection changes physiology.

Safety changes physiology.

This is why I have increasingly moved away from asking only:

“What are you thinking?”

and towards also asking:

“What is happening inside you while you think it?”

That is where taVNS fits naturally into my clinical thinking.

Not because electrical stimulation replaces psychological understanding.

Because physiology and psychology were never separate to begin with.

The Brain-Body Loop

The nervous system is continuously exchanging information.

What is happening in the body influences the brain.

What is happening in the brain influences the body.

The process is bidirectional.

This matters when someone experiences chronic stress or trauma.

A thought may trigger physiological activation.

That activation then influences how the person interprets the situation.

The interpretation creates more activation.

The loop reinforces itself.

For example:

A person notices that their partner has become quiet.

The brain interprets the silence as rejection.

The body activates.

Heart rate changes.

Muscle tension increases.

Attention narrows.

The activated body now makes the situation feel even more threatening.

The person becomes more certain that something is wrong.

Nothing in that sequence is purely psychological.

Nothing is purely physiological.

It is a system.

Where Polyvagal Theory Fits

This brings us to an area where I think we need to be particularly careful.

I am a Polyvagal-Informed Practitioner.

Polyvagal Theory has significantly influenced the way I think about safety, connection, mobilisation, shutdown and the role of the autonomic nervous system in therapy.

But Polyvagal Theory and taVNS are not the same thing.

And we should not pretend they are.

Polyvagal Theory is a theoretical framework concerned with autonomic state, evolutionary organisation, social engagement and responses to perceived safety and threat.

taVNS is a neuromodulation technique involving electrical stimulation of auricular sensory pathways associated with the vagus nerve.

The fact that both involve the vagus nerve does not mean taVNS is a direct technological implementation of Polyvagal Theory.

That would be an overreach.

What we can say is that they can sit alongside each other clinically.

Polyvagal-informed thinking gives us a language for exploring:

Safety.

Mobilisation.

Connection.

Shutdown.

Flexibility.

taVNS provides a potential physiological intervention that may influence autonomic and central nervous-system processes.

At Pesona Jiwa, we integrate the two at the level of practice, not as though one scientifically proves the other.

That distinction matters enormously.

Polyvagal-Informed Does Not Mean “Vagus Nerve Therapy”

This is another misunderstanding I see increasingly.

People hear Polyvagal Theory and assume the therapeutic goal is to stimulate the vagus nerve.

It is not.

Polyvagal-informed psychotherapy may involve exploring:

How safety is experienced.

How the body responds to relationships.

How mobilisation develops.

How shutdown appears.

What allows connection.

What increases flexibility.

How someone moves through states.

The vagus nerve is part of the theoretical framework.

But therapy is not simply an exercise in trying to increase vagal activity.

That would reduce a complex psychological and relational model to one biological variable.

What We Mean by Safety

Safety is another word that has become oversimplified.

Safety does not mean:

Nothing uncomfortable happens.

No one disagrees with you.

You never become anxious.

Life is predictable.

Safety is better understood as enough support and internal capacity to remain present through experience.

This fits very closely with the way we discuss regulation in How to Regulate Your Nervous System (What Actually Works).

A regulated nervous system is not permanently calm.

It can experience challenge and recover.

That is the model I bring into our taVNS work.

The aim is not to use a device to remove every uncomfortable state.

It is to support a wider process in which the person develops more capacity.

Why Safety Cannot Come From a Device Alone

This point is fundamental.

A device cannot make a relationship safe.

It cannot set a boundary.

It cannot reduce an impossible workload.

It cannot provide secure attachment.

It cannot resolve grief.

It cannot create meaning.

It cannot change a workplace that is chronically abusive.

It cannot replace sleep.

If someone is living in an environment that repeatedly communicates threat, physiological support may help them manage.

But we should also ask why the system is being asked to regulate inside that environment.

This is where nervous-system work can become distorted.

The individual is told:

“Regulate yourself better.”

But perhaps the environment itself needs to change.

I have written about this extensively because I think it is one of the most important questions in nervous-system regulation:

What keeps activating the nervous system?

taVNS does not remove the need to ask that.

If anything, responsible integration should make us ask it more carefully.

taVNS and the Window of Tolerance

The Window of Tolerance provides another useful clinical framework.

Within this window, the person generally has enough capacity to:

Think.

Feel.

Remain present.

Connect.

Reflect.

Respond rather than react.

When activation exceeds capacity, they may move into hyperarousal.

Anxiety.

Panic.

Hypervigilance.

Anger.

Racing thoughts.

When the system becomes overwhelmed in another direction, the person may move towards hypoarousal.

Numbness.

Disconnection.

Withdrawal.

Functional freeze.

The goal of therapy is not to force someone to stay in one perfect state.

It is to gradually increase flexibility and capacity.

This is where I become interested in whether taVNS can sometimes support the therapeutic window.

Not by eliminating emotion.

But potentially by reducing enough internal activation that someone can remain present with what we are working on.

That is a clinical question.

And it is very different from saying:

“taVNS treats trauma.”

Staying Present Is Often More Important Than Going Deeper

People frequently assume trauma therapy is about reaching the deepest material as quickly as possible.

It is not.

If someone is overwhelmed, flooded or dissociated, more intensity may not produce better therapy.

Sometimes the most important achievement is simply staying present.

Feeling emotion without disappearing into it.

Remembering something without becoming completely flooded.

Talking about a relationship while noticing the body.

Remaining connected to the therapist.

This is why regulation and psychotherapy belong together.

If taVNS helps some people remain more available for that process, then that is clinically meaningful.

But again, we have to test that person by person.

Why We Do Not Chase a “Parasympathetic State”

Another phrase I would like to challenge is:

“You need to get into your parasympathetic nervous system.”

The parasympathetic system plays critical roles in rest, digestion and recovery.

But life is not meant to be lived permanently in one autonomic state.

You need sympathetic mobilisation to exercise.

Respond to danger.

Perform.

Create.

Act.

The problem is not sympathetic activation.

The problem is losing flexibility.

This is particularly relevant in burnout.

Many high performers have become extremely skilled at mobilising.

Their difficulty is returning.

That is one reason taVNS has attracted attention in chronic stress and autonomic research.

But again, the goal is not to suppress activation completely.

The goal is improving the ability to move.

How Do Researchers Know the Vagus Is Being Engaged?

This is a harder question than it appears.

Researchers use several approaches.

Functional MRI.

Evoked potentials.

Autonomic measurements.

Heart-rate variability.

Heart rate.

Pupil responses.

Electrophysiological measures.

Behavioural outcomes.

The difficulty is that none of these provides a perfect universal marker of successful vagal engagement.

HRV is a good example.

It is frequently discussed as though it is a direct “vagus nerve score.”

It is not.

Heart-rate variability is influenced by numerous factors.

Breathing.

Age.

Fitness.

Sleep.

Medication.

Posture.

Time of day.

Health.

Measurement method.

It can be useful.

But it should not be treated as a simple readout telling someone whether their vagus nerve is working.

The same caution applies to many proposed biomarkers in taVNS research.

More Data Does Not Automatically Mean More Understanding

Wearable technology has made people increasingly interested in measuring their nervous system.

HRV.

Sleep scores.

Stress scores.

Recovery scores.

These can provide useful patterns.

They can also create anxiety.

A person wakes feeling good.

Their device says their recovery score is poor.

Now they feel worried.

They begin treating the number as more trustworthy than their own experience.

This is not regulation.

It can become another form of vigilance.

Technology should provide information.

It should not replace interoception.

The ability to notice:

How do I actually feel?

What is my energy like?

How reactive am I?

How am I sleeping?

How connected do I feel?

These subjective measures still matter.

Stimulation Parameters Matter

This may be one of the biggest challenges in the taVNS literature.

When we say “taVNS,” we are grouping together studies that may differ substantially.

Frequency.

Pulse width.

Intensity.

Duty cycle.

Stimulation location.

Session duration.

Number of sessions.

Unilateral versus bilateral use.

Different devices.

Different clinical populations.

A recent broad review of taVNS mechanisms and applications again highlights substantial protocol diversity, with sessions ranging from single exposures to repeated daily interventions extending over weeks or months.

That means one study cannot automatically be generalised to every device or protocol.

This is one of the reasons commercial claims need restraint.

The phrase:

“Research shows taVNS does X”

may hide enormous methodological variation.

The more useful question is:

“What type of taVNS, using what parameters, showed what effect in which population?”

Why Intensity Is Not About Tolerance

People sometimes assume that stronger stimulation must be better.

That is not necessarily how neuromodulation works.

There is no reason to turn stimulation intensity into another endurance test.

The appropriate dose needs to produce adequate sensory stimulation without unnecessary discomfort.

Protocols often individualise intensity according to perceptual thresholds or tolerability.

This makes sense clinically.

Particularly when working with people whose nervous systems are already highly activated.

Creating excessive discomfort in the name of regulation would be contradictory.

Why Repetition Probably Matters

One of the things I find clinically interesting about taVNS is the question of repetition.

Nervous systems learn through repetition.

Therapy works through repeated experience.

Behavioural change works through repeated action.

The research literature also frequently uses repeated taVNS sessions rather than assuming a single stimulation produces permanent change.

This fits with the way we structure our 28-Day taVNS Intensive.

The emphasis is not on one dramatic session.

It is on repeated exposure within a broader therapeutic process.

That does not mean 28 days is a scientifically established universal duration for taVNS.

It is not.

Our programme duration is our clinical model.

What matters is that we do not misrepresent it as though every taVNS study proves that 28 days is the required protocol.

The evidence and our programme design are related, but they are not identical.

Why Our 28-Day Model Is Broader Than Stimulation

The 28 days allow us to work with much more than the device.

Psychotherapy.

Patterns.

Sleep.

Boundaries.

Stress.

Movement.

Relationships.

Emotional awareness.

The experience of rest.

The way someone responds when nothing is required from them.

This matters because the person returning home needs more than physiological stimulation.

They need understanding.

Choice.

A different relationship with their nervous system.

That is what makes the programme a nervous-system recovery programme rather than simply extended device use.

The Most Interesting Question Is Still Clinical

For me, the real question is not:

“Can we show that electrical stimulation reaches a brainstem pathway?”

That matters scientifically.

But clinically, I want to know:

Does the person sleep differently?

Recover more quickly after activation?

Remain present during therapy?

Feel less overwhelmed?

Recognise their triggers earlier?

Begin setting boundaries?

Return to relationships?

Feel more emotionally available?

Regain capacity?

Those outcomes are why the neuroscience matters.

The biology should serve the person.

Not become another fascinating explanation that never changes their life.

Where the Science Is Strong and Where It Is Still Developing

At this stage, I would summarise the mechanism evidence like this:

We have credible anatomical reasons for targeting areas of the external ear associated with the auricular branch of the vagus nerve.

Neuroimaging and physiological research suggests auricular stimulation can engage vagal afferent pathways and influence distributed brain networks.

The NTS and related brainstem systems are frequently implicated.

Different stimulation sites and parameters appear to produce different responses.

But there is still no single universally accepted optimal taVNS protocol.

And the field continues to refine how best to demonstrate target engagement and translate it into reliable clinical outcomes.

That is a healthy scientific position.

We know enough to investigate seriously.

We still have plenty to learn.

And that is where I believe taVNS should remain.

Neither dismissed.

Nor turned into another miracle.

What Does the Research Actually Say taVNS May Help With?

This is where we need to be careful.

Once people hear that taVNS may influence brainstem pathways, autonomic regulation and wider neural networks, it is tempting to make the next leap:

“So what does it treat?”

That is understandable.

But it is also where much of the online discussion becomes too confident.

taVNS is being studied across a surprisingly wide range of conditions.

Depression.

Anxiety.

Sleep.

Pain.

Epilepsy.

Migraine.

Inflammatory conditions.

Cognitive function.

PTSD.

Burnout.

The problem is that these areas are not all supported by the same quality of evidence.

Some have randomised controlled trials.

Some have systematic reviews.

Some have small feasibility studies.

Some have promising mechanistic findings but very limited clinical outcome data.

And some are still much closer to hypothesis than established treatment.

That distinction matters enormously.

At Pesona Jiwa, I do not want to tell somebody:

“taVNS treats your trauma.”

Or:

“taVNS fixes burnout.”

Or:

“This will regulate your nervous system.”

I think that language is too absolute.

A more useful way to approach the research is:

Where is the evidence strongest?

Where is it promising?

Where is it still early?

And where might taVNS make sense as one part of a broader therapeutic process?

That is what I want to look at here.

taVNS and Depression

Depression is one of the more developed areas of taVNS research.

That makes sense partly because implanted vagus nerve stimulation already has a history within treatment-resistant depression.

But again, implanted VNS and taVNS are not interchangeable.

The interesting question is whether a non-invasive auricular approach may produce clinically meaningful changes in depressive symptoms.

A systematic review and meta-analysis published in 2023 examined 12 studies involving 838 participants with depressive disorders.

The analysis found reductions in depression scores with taVNS, but the authors were also very clear that the quality of evidence for several comparisons was low or very low and that the number of studies within subgroups remained small.

That is encouraging.

It is not definitive.

A separate systematic review published in 2024 examined clinical, neural and inflammatory effects of transauricular VNS in major depressive disorder.

It found only five clinical studies specifically evaluating depressive patients and highlighted considerable methodological heterogeneity and limited data.

This is exactly the kind of evidence base I find interesting.

There appears to be a signal.

But it is not yet an excuse to speak with certainty.

Why Depression Is Relevant to Nervous System Work

Depression is not simply a “low mood problem.”

People may experience:

Reduced motivation.

Emotional numbness.

Sleep disturbance.

Fatigue.

Changes in concentration.

Social withdrawal.

Loss of pleasure.

Some become highly slowed down.

Others remain outwardly functional while feeling internally disconnected.

These are very different experiences.

It is therefore unlikely that one simple autonomic explanation accounts for every presentation.

taVNS research into depression is interesting partly because the proposed mechanisms go beyond one pathway.

Researchers have explored autonomic effects, neural connectivity, inflammatory pathways and neurotransmitter systems.

But those remain areas of investigation rather than one settled mechanism.

For me clinically, the important question is not:

“Does stimulation increase this neurotransmitter?”

It is:

Does the person become more available for life?

Do they begin reconnecting?

Sleeping differently?

Engaging in psychotherapy?

Recovering some emotional range?

Those are the outcomes that matter.

taVNS Is Not a Replacement for Depression Treatment

This needs saying clearly.

If someone has major depressive disorder, particularly severe depression, suicidal thinking, significant functional impairment or other psychiatric risk, taVNS should not be used as an excuse to avoid proper assessment and treatment.

Psychotherapy may be appropriate.

Medication may be appropriate.

Psychiatric care may be appropriate.

Other interventions may be appropriate.

taVNS may eventually have an important role in some treatment pathways.

But “promising evidence” does not mean:

“Throw away established care and stimulate your ear.”

That would be irresponsible.

taVNS and Anxiety

Anxiety is another area attracting substantial interest.

And this is where people often become very excited because the symptoms seem intuitively connected to autonomic activation.

Racing thoughts.

Restlessness.

Tension.

Palpitations.

Hypervigilance.

Difficulty switching off.

The temptation is to say:

“Anxiety is sympathetic activation, therefore stimulate the vagus nerve and reduce anxiety.”

Again, real life is more complicated.

Anxiety can involve:

Learned fear.

Cognitive patterns.

Trauma.

Attachment.

Physical illness.

Substances.

Sleep deprivation.

Environmental stress.

Relationship dynamics.

And many other factors.

Still, there are emerging trials suggesting taVNS may influence anxiety symptoms in particular contexts.

For example, a 2024 double-blind randomised controlled trial involving university students with elevated anxiety examined taVNS effects on anxiety alongside muscle activity and pain measures.

There are also ongoing and completed studies examining taVNS in distressed healthcare professionals, including anxiety, depression, burnout and insomnia measures.

This tells us the field is moving.

But I would still describe anxiety evidence as promising and developing, rather than established.

Why Anxiety Is Not Simply “Too Much Sympathetic Activity”

This is important.

Not all anxiety looks the same.

One person becomes restless.

Another freezes.

One becomes controlling.

Another avoids.

One seeks reassurance.

Another withdraws.

The nervous system pattern is only part of the picture.

The meaning attached to the threat matters too.

A person afraid of abandonment does not simply need their heart rate reduced.

They may need to understand what relational distance means to them.

A person terrified of making mistakes may need to work with perfectionism and shame.

Someone living in an unsafe relationship may not need better self-regulation.

They may need safety.

taVNS might influence physiological activation.

It cannot answer those questions.

That is why I keep returning to integration.

Where taVNS May Help Anxiety Clinically

One area I find interesting is the possibility that physiological support may create slightly more room between sensation and reaction.

If internal activation reduces even modestly, some people may find it easier to:

Stay in a difficult conversation.

Notice anxiety without immediately escaping.

Participate in therapy.

Sleep.

Interrupt rumination.

Use coping strategies they already know.

Again, that is not the same as claiming taVNS treats the cause of anxiety.

It may support the person’s ability to work with it.

That is a much more realistic clinical position.

taVNS and PTSD

Trauma is where I become particularly cautious.

There is a huge difference between saying:

“taVNS is being investigated in PTSD”

and:

“taVNS heals trauma.”

At present, the PTSD evidence is early.

A recent randomised, double-blind, sham-controlled feasibility study involving 32 World Trade Center responders with PTSD examined eight weeks of daily taVNS.

The study was primarily designed to assess feasibility and acceptability. Some participants receiving active stimulation showed reductions in clinician-rated PTSD symptoms, but significant group differences were not found across all self-reported outcomes, and the authors concluded that larger studies are needed.

That is interesting.

It is not a treatment verdict.

And I think it would be misleading to present it as one.

Trauma Is Not a Vagus Nerve Deficit

I want to be especially clear about this.

Trauma is not simply a poorly functioning vagus nerve.

It is not something sitting in the ear waiting to be electrically corrected.

Trauma can affect:

Memory.

Identity.

Relationships.

Trust.

Beliefs.

Emotion.

Body responses.

Sleep.

Attachment.

Sense of safety.

How someone interprets the present.

A physiological intervention cannot process all of that.

This is why our article Healing Trauma Through the Nervous System at Pesona Jiwa Retreats places such emphasis on psychotherapy, safety, relationship, environment and nervous-system flexibility.

taVNS may be relevant within that process.

It is not the process itself.

Why taVNS and Psychotherapy May Be an Interesting Combination

This is where I think the more meaningful question sits.

Trauma therapy often requires the person to remain present while approaching material that historically triggered intense activation or shutdown.

Too much activation and the person may become flooded.

Too little and they may dissociate or disconnect.

The work often happens somewhere between those extremes.

If taVNS can, for some people, influence physiological arousal or support broader regulatory capacity, then one potential use is not:

“Treat the trauma with stimulation.”

It is:

“Can stimulation help create conditions in which therapy becomes more tolerable or accessible?”

That is an entirely different research question.

And one I think deserves much more attention.

taVNS and Burnout

This is another area where I think the marketing potential could easily run ahead of the evidence.

There is emerging research.

But the direct burnout literature remains very limited compared with depression or sleep.

A 2025 study investigated the immediate effects of transcutaneous vagus nerve stimulation on executive-function-related neural processing in people with and without occupational burnout.

It included 27 participants with burnout and 24 without. Active stimulation was associated with changes in some neural processing measures, but improvements in behavioural executive-function performance were clearer in participants without burnout than in the burnout group. The authors themselves urged caution and described the findings as suggestive rather than definitive.

There is also an earlier tiny exploratory report involving only six young male participants, which is nowhere near enough to establish clinical efficacy for burnout.

That tells us something important.

There is a rationale for studying taVNS in burnout.

There is not yet a strong evidence base for claiming taVNS is a proven burnout treatment.

Why I Am Still Interested in taVNS for Burnout

Because burnout is not only exhaustion.

As we have explored in When High Performers Start to Burn Out: What We Often See, it often involves:

Difficulty switching off.

Reduced recovery.

Sleep disruption.

Emotional withdrawal.

Chronic activation.

Decision fatigue.

Reduced cognitive flexibility.

Sometimes functional freeze.

Many of those areas overlap with domains being investigated in taVNS research.

That makes taVNS clinically interesting.

But it also means we need to be disciplined.

We can say:

taVNS is being studied in areas relevant to burnout, including autonomic regulation, cognition, sleep, stress and mood.

We can say:

early burnout-specific studies are emerging.

We cannot honestly say:

taVNS has been established as an effective treatment for burnout.

Not yet.

Burnout Is a Whole-System Problem

This is another reason a device-only approach would not make sense.

Burnout may involve:

An impossible workload.

Hyper-responsibility.

Perfectionism.

Poor boundaries.

Sleep deprivation.

Work becoming identity.

Relational stress.

Trauma history.

No amount of electrical stimulation changes the fact that somebody is working 80 hours a week in an unsafe environment.

taVNS may support regulation.

The life still needs to change.

That is why we integrate it within our 28-Day taVNS Intensive, rather than presenting it as a passive reset.

The person still has to look at what has been driving the system.

taVNS and Stress

Stress research is another area worth watching.

A recent experimental study reported that taVNS reduced cortisol release during a laboratory mental-stress paradigm, although this type of mechanistic finding should not be confused with proof that taVNS treats chronic stress as a clinical condition.

This is a good example of how research headlines can become misleading.

“taVNS reduces cortisol during a stress experiment”

can quickly become:

“taVNS fixes your stress hormones.”

Those are not the same statement.

Cortisol is dynamic.

It changes throughout the day.

It is influenced by sleep, illness, activity, psychological stress and many other factors.

The finding is interesting.

It tells us taVNS may influence aspects of stress physiology.

It does not mean cortisol becomes the reason to buy a device.

taVNS and Sleep

Sleep is one of the more interesting areas of emerging taVNS evidence.

And unlike burnout, there are now several controlled studies.

A 2024 randomised clinical trial published in JAMA Network Open enrolled 72 people with chronic insomnia disorder.

Participants received either active or sham taVNS over eight weeks.

The active group showed a clinically meaningful greater improvement in Pittsburgh Sleep Quality Index scores, and improvements were maintained during follow-up. The researchers nevertheless called for larger multicentre trials across more diverse populations.

A later 2025 double-blind randomised sham-controlled study involving 40 participants also reported improvements in sleep quality and insomnia severity with active taVNS.

And a 2025 systematic review and meta-analysis pooling six studies and 336 patients found statistically significant improvements in sleep quality and insomnia severity, while grading the evidence as low for one major sleep outcome and very low for another.

That last point matters.

A positive meta-analysis does not automatically equal high-certainty evidence.

The direction is promising.

Confidence still needs to improve.

Why Sleep Matters Beyond Insomnia

Sleep is particularly relevant to our work because it sits underneath so many other difficulties.

Burnout.

Anxiety.

Emotional regulation.

Concentration.

Trauma recovery.

When sleep deteriorates, almost everything becomes harder.

People become more reactive.

Less able to concentrate.

Less emotionally flexible.

The nervous system begins each day with reduced capacity.

This is why if someone using taVNS begins sleeping more deeply or recovering more effectively, I pay attention.

Not because sleep improvement proves a universal mechanism.

Because it can create the capacity for other therapeutic work.

taVNS Is Not a Replacement for CBT-I

Chronic insomnia deserves proper assessment.

Cognitive Behavioural Therapy for Insomnia remains an important evidence-based treatment.

Sleep apnoea needs assessment.

Medication effects matter.

Substance use matters.

Circadian problems matter.

Anxiety matters.

taVNS should not become another way to avoid understanding why someone cannot sleep.

Again, the technology should sit inside good care.

Not replace it.

taVNS and Pain

Pain is another major research area.

This makes biological sense because pain is not simply a signal from damaged tissue.

It involves central processing, attention, emotion, expectation and autonomic state.

taVNS has therefore been studied across different pain conditions and experimental pain paradigms.

But pain is a broad category.

Migraine is not the same as fibromyalgia.

Neuropathic pain is not the same as acute injury.

Chronic pelvic pain is not the same as postoperative pain.

So we should resist saying:

“taVNS treats pain.”

A better description is:

taVNS is being investigated across multiple pain conditions, with promising findings in some areas and substantial variation between study designs and populations.

That distinction protects the person from unrealistic expectations.

taVNS and Inflammation

The vagus nerve is also frequently discussed in relation to inflammatory regulation.

Researchers have explored what is sometimes referred to as the inflammatory reflex, including neural signalling pathways capable of influencing immune activity.

This is scientifically fascinating.

It is also becoming a marketing minefield.

You will increasingly see statements such as:

“Stimulate your vagus nerve to reduce inflammation.”

That is far too simple.

Inflammation is not one thing.

It may be part of:

Infection.

Autoimmune illness.

Injury.

Metabolic disease.

Chronic medical conditions.

The idea that all inflammation can be regulated through vagal stimulation is not supported.

What we can say is that neural-immune interaction is a serious field of research and vagal pathways appear to participate in aspects of inflammatory regulation.

How clinically meaningful non-invasive auricular stimulation will prove across different diseases remains under investigation.

taVNS and Cognitive Function

There is also growing interest in cognition.

Attention.

Response inhibition.

Executive function.

Memory.

This is relevant to high performers because cognitive symptoms are often what finally frighten them enough to seek help.

They say:

“My brain is not working properly anymore.”

“I keep forgetting things.”

“I cannot make decisions.”

“I used to think quickly.”

The burnout study I mentioned earlier is particularly interesting in this context because it examined executive-function-related neural processing rather than simply asking whether people “felt less burned out.”

Again, though, one study does not establish cognitive enhancement as a clinical indication.

It points towards an area worth exploring.

The Difference Between a Clinical Indication and an Area of Research

This distinction should probably be made explicit.

An established clinical indication means there is sufficient evidence and regulatory acceptance for a treatment to be used for a particular condition within a defined medical context.

An area of research means scientists are investigating whether an intervention may have value.

taVNS currently has many areas of research.

That does not mean it has an established indication for every one of those conditions.

This is particularly important when commercial devices are available directly to consumers.

The existence of a device does not automatically mean every proposed use has been clinically established.

What Does This Mean for Pesona Jiwa?

It means we should resist the temptation to build our taVNS programme around diagnoses.

We should not say:

Come for 28 days and we will treat your PTSD with taVNS.

Or:

taVNS will cure your burnout.

Or:

This is the answer to your depression.

That is not our model.

Our model is nervous-system recovery.

The person is assessed as a whole.

Psychotherapy remains central.

taVNS may be integrated as one physiological support.

Then we look at what actually changes.

Sleep.

Activation.

Emotional availability.

Capacity.

Therapeutic engagement.

Recovery after stress.

That is a much more defensible position.

What I Have Observed Is Not the Same as Research

This distinction matters enough to repeat.

When I say:

“Some people I work with report feeling calmer after taVNS,”

that is a clinical observation.

When a randomised controlled trial reports a statistically significant change compared with sham stimulation, that is research evidence.

Both can be useful.

They should never be presented as though they are the same.

My experience can help generate questions.

It can help us understand how something may fit into practice.

It cannot replace controlled research.

Equally, research does not always tell us exactly how one individual sitting in front of us will respond.

Good clinical work requires both humility and observation.

Why “It Worked for Me” Is Not Enough

This is particularly important in nervous-system communities online.

People say:

“This changed my life.”

That matters to the person.

It does not establish a universal treatment effect.

There may be:

Placebo effects.

Expectation.

Natural symptom variation.

Other treatments happening simultaneously.

Lifestyle changes.

Relationship changes.

Improved sleep.

Regression to the mean.

None of this means the experience was not real.

It means individual experience cannot tell us exactly why the change occurred.

This is why research matters.

Why Sham-Controlled Trials Matter in taVNS

Neuromodulation studies have an interesting challenge.

People can often feel the stimulation.

That makes blinding difficult.

If someone believes they are receiving the real treatment, expectation may influence reported outcomes.

Researchers therefore use sham stimulation.

But designing a convincing sham is complicated.

Stimulate too little and participants may know they are in the control group.

Stimulate another part of the ear and the sham itself may produce physiological effects.

This is one reason we should expect some inconsistency between studies.

taVNS research is not easy.

Evidence Can Be Promising Without Being Finished

I think this is perhaps the most balanced place to land.

taVNS is not fringe pseudoscience.

There is real anatomy.

Real neurophysiology.

Randomised trials.

Neuroimaging.

Systematic reviews.

And a rapidly expanding research literature.

But neither is it a finished technology with one standard protocol and a long list of proven indications.

The evidence is developing at different speeds across different areas.

Depression has a meaningful but still limited evidence base.

Sleep is increasingly promising.

Anxiety is developing.

PTSD remains early.

Burnout research is very early.

Mechanistic research continues across autonomic, neural and inflammatory pathways.

That is exciting enough.

We do not need to exaggerate it.

What I Have Observed When Using Zenowell taVNS During Psychotherapy

This next section is not research data.

It is my own clinical observation from using the Zenowell device alongside psychotherapy.

I want to make that distinction very clear.

In almost all of the cases where I have integrated taVNS into psychotherapy sessions, I have noticed what appears to be a relatively rapid settling of the nervous system.

The person often seems calmer.

Less internally activated.

More able to remain present.

What I find particularly interesting is what sometimes happens next.

People often begin opening up more quickly.

There appears to be less resistance around material that would normally carry a much greater emotional charge.

They seem more able to talk about difficult experiences, including trauma, in a more matter-of-fact way.

The events have not disappeared.

The memory is still there.

The person still understands what happened and why it mattered.

But the relationship with the memory can appear different in the room.

At times, it almost feels as though the person is able to view the experience from a greater distance.

I sometimes describe this as something similar to a helicopter view.

They are still looking at what happened.

But they do not appear to be standing directly inside it.

That distinction can be important.

When trauma is highly activated, the person may not simply remember the event.

Their nervous system can respond as though some part of the threat is happening again.

The body reacts.

Attention narrows.

Emotion intensifies.

The person may become overwhelmed, shut down, disconnected or unable to think clearly.

What I have sometimes observed when taVNS is used alongside psychotherapy is that the emotional and physiological impact of revisiting the event appears reduced.

The person can still access the memory.

But it does not seem to carry quite the same immediate force.

That can create more room for reflection.

And when that room appears, answers often seem more accessible.

The person may begin making connections they were previously unable to make.

They can look at causes and conditions.

Recognise patterns.

Understand why certain behaviours developed.

See how one event connected with another.

And sometimes question beliefs they have carried for years.

The event itself has not changed.

But its immediate impact in the present moment appears to have shifted.

From a therapeutic perspective, this is what interests me most.

Not whether someone simply says:

“I feel calmer.”

But whether that reduction in activation allows them to engage differently with the work.

Can they stay present?

Can they explore without becoming overwhelmed?

Can they talk about the past without feeling completely pulled back into it?

Can they recognise patterns without immediately defending against them?

Can they access insight while remaining emotionally connected enough for the work to matter?

In some sessions, I have seen people approach traumatic material with a degree of distance that was not previously available to them.

They are not denying what happened.

They are not minimising it.

They are simply able to look at it from somewhere different.

That can reduce the sense of being retraumatised by the process of revisiting the event.

Again, I want to be precise with the language here.

I am not claiming that taVNS prevents retraumatisation.

I am not claiming that it removes the emotional impact of trauma.

And I am not presenting these observations as controlled research findings.

They are clinical observations.

But they are consistent enough in my own work that I believe they deserve serious attention.

What I appear to be seeing is not the removal of memory.

It is a change in the person’s ability to remain regulated while engaging with that memory.

And that is potentially very important.

Because trauma recovery is not about forgetting what happened.

It is about changing what happens inside the person when they remember.

When the nervous system is less overwhelmed, the past may become easier to examine without the present being completely taken over by it.

That is where I see the most interesting potential relationship between taVNS and psychotherapy.

Not as a replacement for therapy.

Not as a device that “treats trauma.”

But as a possible way of helping some people remain safe enough, present enough and regulated enough to do deeper therapeutic work.

For me, that is the area that deserves much more formal research.

The More Interesting Question Is How We Integrate It

For me, the real opportunity is not proving that one device can replace everything else.

It is asking how neuromodulation might sit beside:

Psychotherapy.

Polyvagal-informed practice.

Sleep.

Movement.

Human connection.

Environmental safety.

Behaviour change.

And repeated nervous-system learning.

That is exactly how we use taVNS at Pesona Jiwa.

Not as the hero.

Not as the cure.

As one part of the wider process.

And that brings us to perhaps the most important practical question in this entire guide:

What actually happens during taVNS treatment, how often is it used, how long might it take, and why does repetition matter?

What Does a taVNS Session Actually Look Like?

This is usually where people want the conversation to become practical.

What actually happens?

How long do you use the device?

What should it feel like?

How strong should the stimulation be?

How often do you use it?

And how quickly should somebody expect to notice anything?

The difficulty is that there is no single universal taVNS protocol.

That is not me avoiding the question.

It is the reality of the research.

Different studies use different:

• frequencies
• pulse widths
• stimulation intensities
• ear locations
• session durations
• treatment schedules
• devices
• unilateral or bilateral stimulation

A recent review of taVNS applications found substantial variation across these parameters, and a 2024 scoping review of 109 studies reached the same conclusion: there is still no universally accepted optimal protocol.

That matters because people increasingly talk about taVNS as if it is one intervention.

It is not.

The phrase tells us broadly what is being stimulated and how.

It does not tell us the exact dose.

What Should taVNS Feel Like?

Generally, people notice a mild electrical or tingling sensation around the ear.

Sometimes it feels like:

A gentle pulse.

A tingling.

A light buzzing sensation.

A mild rhythmic stimulation.

It should not become an exercise in endurance.

This is particularly important for many of the people I work with.

They are already very good at pushing through discomfort.

They have spent years overriding themselves.

They do not need to come into nervous-system work and immediately think:

“If level four is good, level eight must be better.”

That mentality completely misses the point.

More sensation does not automatically mean a better neurological effect.

More discomfort does not mean the vagus nerve is being stimulated more effectively.

And stronger is not automatically better.

The research itself varies widely in intensity, with many studies setting stimulation around an individual sensory threshold rather than simply turning the current as high as can be tolerated. Reviews report considerable variation in electrical dose and confirm that the optimal combination of frequency, pulse width and intensity remains unresolved.

The aim is appropriate stimulation.

Not maximum stimulation.

Frequency, Pulse Width and Intensity

These are three terms people will frequently encounter when reading about taVNS.

Frequency refers to how often electrical pulses are delivered and is generally expressed in hertz.

Pulse width describes how long each individual electrical pulse lasts.

Intensity describes the amount of electrical current being delivered.

All three can influence how stimulation is experienced and potentially how neural tissue responds.

Published taVNS studies have used a wide range of frequencies.

A recent review summarised protocols using frequencies from around 1 Hz through to much higher settings, with 20–25 Hz appearing commonly across parts of the literature. Pulse widths also vary substantially, often falling within the hundreds of microseconds.

But I want to resist turning those ranges into a prescription.

Because that is exactly how misinformation starts.

A research paper uses 25 Hz.

An article says 25 Hz is effective.

A social-media post says:

“25 Hz is the scientifically proven vagus nerve frequency.”

That is not what the evidence says.

What it tells us is that particular studies used particular settings in particular populations.

That is very different.

Why There Is No Single “Best” taVNS Setting

Different research groups are trying to answer different questions.

A study investigating depression may use one protocol.

A sleep study may use another.

A motor-rehabilitation study may use another.

A laboratory study looking at attention may deliver only one stimulation session.

A clinical trial may deliver stimulation daily for several weeks.

So when someone asks:

“What is the scientifically proven taVNS setting?”

the honest answer remains:

There is not currently one universal setting that has been shown to be best across all uses.

That uncertainty does not make taVNS meaningless.

It means the field is still developing.

How Long Does a taVNS Session Last?

Again, it varies.

Some research uses relatively short experimental sessions.

Other studies use 30 minutes or longer.

Some protocols repeat stimulation more than once per day.

Others use daily or near-daily sessions over weeks.

Recent reviews demonstrate just how variable the schedules are, from single laboratory exposures to repeated treatment programmes lasting weeks or months.

This is why I would be very cautious of anyone claiming:

“You need exactly X minutes.”

We do not have that universal answer.

Does taVNS Work Immediately?

Sometimes people report an immediate subjective change.

I have seen that myself.

But this needs separating into two different questions.

Can somebody notice something during or shortly after a session?

Yes.

Some do.

Does an immediate sensation mean lasting nervous-system change has occurred?

Not necessarily.

That distinction matters.

Feeling calmer for thirty minutes is not the same as changing a long-standing pattern of nervous-system response.

A person can experience an immediate state shift without yet having developed greater long-term capacity.

For me, both may be clinically useful.

But they are not the same outcome.

What I Have Observed During Psychotherapy Sessions

This is where my own experience with Zenowell has become particularly interesting.

And again, I want to mark this very clearly:

What follows is my clinical observation. It is not controlled research data.

When I use the Zenowell device during psychotherapy, in almost all cases I notice what appears to be a relatively immediate calming or settling of the nervous system.

The change is sometimes subtle.

But it can also be quite noticeable.

The person seems less internally activated.

More present.

Less guarded.

What interests me much more than simply hearing somebody say:

“I feel calmer”

is what often happens to the psychotherapy.

I frequently notice clients opening up more quickly.

Material that may previously have been difficult to approach seems more accessible.

They appear to feel safe enough to explore experiences that carry significant emotional weight.

And often they do so in a more matter-of-fact way.

That phrase matters.

Because they are not necessarily emotionally disconnected.

They are not pretending the event did not matter.

They are still aware of what happened.

But they seem less consumed by the event while speaking about it.

The “Helicopter View”

The closest way I can describe what I sometimes observe is a helicopter view.

The person is still able to see the event.

But instead of appearing to stand directly inside it, they seem able to look at it from slightly above.

There is distance.

Perspective.

The memory remains.

The facts remain.

The person is not denying their experience.

But the immediate emotional and physiological impact appears to be different.

This can be particularly striking when we are exploring the causes and conditions behind long-standing patterns.

A relationship.

An abandonment.

An abusive experience.

A significant loss.

Something that shaped the person’s belief about themselves.

Previously, revisiting the event may have pulled them rapidly into the old state.

The body reacts.

Attention narrows.

Emotion becomes overwhelming.

They may shut down.

Become highly activated.

Lose perspective.

What I sometimes observe with taVNS running during the psychotherapy session is that the person can remain alongside the memory without appearing to be pulled quite so deeply back into it.

The Event Is Still There

This is an important distinction.

I am not observing memories disappearing.

Nor would I expect that.

The event happened.

The history remains.

What appears different is the person’s relationship with what they are remembering.

The event is still accessible.

But it does not appear to carry exactly the same force in that moment.

And when that occurs, something else becomes possible.

Reflection.

Answers Sometimes Become More Accessible

One of the most interesting things I have noticed is that people often seem more able to make sense of what happened.

They see connections.

They recognise patterns.

They understand where a belief came from.

They can look at the event and ask:

What did I learn here?

What did I begin believing about myself?

What was I protecting myself from?

Why did this pattern make sense at the time?

How is it affecting me now?

The answers can appear more accessible because the nervous system is not spending the entire session defending against the material.

There seems to be more room for curiosity.

And curiosity is incredibly valuable in psychotherapy.

Revisiting Without Becoming Completely Re-Immersed

One of the challenges in trauma work is the difference between processing an experience and simply re-experiencing it.

If someone becomes completely overwhelmed every time traumatic material is approached, they may not gain perspective.

They may simply re-enter the old nervous-system response.

That is not necessarily therapeutic.

I therefore pay close attention to whether the person can remain present.

Can they feel?

Think?

Stay connected?

Notice their body?

Remain aware that they are here, now, while remembering something that happened then?

That is often where useful therapeutic work occurs.

And this is where my observations of taVNS interest me most.

In some sessions, it appears to reduce the impact of revisiting the material enough that the person can examine it without becoming completely immersed in it.

I would be careful with the word retraumatisation.

I cannot claim that taVNS prevents retraumatisation.

That would require evidence we do not currently have.

But clinically, I do sometimes observe what appears to be a reduction in the immediate emotional and physiological intensity associated with revisiting difficult experiences.

That is worth investigating.

It May Be the Difference Between Being Inside the Memory and Looking at It

This is probably the simplest way I can explain what I see.

Without enough regulation:

The person can feel as though they are back inside the experience.

With greater capacity:

They can remember the experience while remaining aware that they are no longer there.

That is an enormously important distinction in trauma therapy.

We are not trying to erase memory.

We are trying to change what happens when memory is activated.

I have written elsewhere about this idea in Healing Trauma Through the Nervous System at Pesona Jiwa Retreats.

Healing is not necessarily forgetting what happened.

It is changing what happens inside you when you remember.

My interest in taVNS sits very naturally within that principle.

Why These Observations Need Research

I am deliberately being cautious because I think this is an area that deserves proper study.

If what I am observing clinically is reproducible, there are important questions to investigate.

Does concurrent taVNS during psychotherapy:

Reduce physiological arousal during trauma-focused discussion?

Increase tolerance for emotionally difficult material?

Reduce dissociation?

Improve therapeutic engagement?

Alter subjective safety?

Increase the amount of time someone can remain within a workable therapeutic window?

Change how quickly someone can access insight?

These are questions.

Not conclusions.

And there is a huge difference between the two.

I think good clinical practice often starts by noticing a repeatable pattern and then asking whether research can test it properly.

That is how I regard these observations.

This Is Why I Prefer Integration to Standalone Use

If I only looked at whether somebody reported feeling calm after taVNS, I would find the intervention interesting.

But that would not be enough for me.

What makes it much more interesting is what appears possible when that physiological shift is integrated into psychotherapy.

The device may help create the conditions.

The person still does the work.

They still reflect.

Connect.

Remember.

Question.

Grieve.

Understand.

Set boundaries.

Change behaviour.

taVNS does not provide the answer.

Sometimes it appears to make the answer easier to reach.

That is a very different claim.

And it is much closer to my experience.

Why Repetition Matters

This brings us to the question of treatment length.

If somebody can feel an immediate change, why not simply use taVNS once?

Because short-term state change and longer-term learning are different things.

The nervous system learns through repetition.

Think about what creates dysregulation in the first place.

One traumatic event may have enormous impact.

But many of the patterns people live with are then reinforced repeatedly.

Every time conflict occurs.

Every time the person avoids.

Every time they become hypervigilant.

Every time they override themselves.

Every time they believe:

“I am not safe.”

The nervous system receives more evidence.

Recovery also needs repeated evidence.

I can activate and return.

I can remember and remain present.

I can say no and remain connected.

I can rest and nothing collapses.

I can accept support.

I can feel an emotion without becoming it.

That is the deeper rationale behind repetition.

Why We Use a 28-Day Intensive Model

Our dedicated taVNS programme at Pesona Jiwa runs for 28 days.

I want to be very precise about what that means.

I am not claiming research has established 28 days as the universally optimal taVNS treatment duration.

It has not.

The literature contains many different treatment schedules.

Our 28-day model is a clinical programme design.

The duration creates time.

Time for repeated taVNS use.

But equally importantly:

Time for psychotherapy.

Time for sleep to change.

Time for the person to decompress.

Time for patterns to appear.

Time to practise boundaries.

Time to experience rest.

Time to notice what happens when the usual pressures are removed.

Time to work with what emerges.

That is why the programme is 28 days.

Not because day 28 represents a neurological magic number.

Because sustained recovery work requires more than one intervention.

The Device Is Only One Part of the 28 Days

I want this to remain completely clear.

Someone does not come to Pesona Jiwa to sit with an electrical device attached to their ear for four weeks.

The programme integrates the technology into a much wider process.

Psychotherapy.

Polyvagal-informed work.

Nervous-system education.

Movement.

Meditation and mindfulness.

Massage and body-based support.

Sleep and recovery.

Nutrition.

Nature.

Private space.

And perhaps most importantly:

Repeated experiences of not having to manage everything.

For some of the people we work with, that may itself be one of the most unfamiliar nervous-system experiences they have had in years.

Why Environment Matters During Intensive taVNS Work

Imagine trying to regulate while simultaneously receiving:

Work calls.

Messages.

Deadlines.

Arguments.

Financial pressure.

Family demands.

Notifications.

Then compare that with being temporarily removed from many of those cues.

No commute.

No team to manage.

No shared retreat group.

No requirement to perform socially.

Meals arranged.

A private villa.

A predictable structure.

Therapeutic support available.

This does not mean Bali cures the nervous system.

It does not.

But the reduction of chronic inputs changes the context in which nervous-system work is happening.

And context matters enormously.

Our One-Guest Model Is Particularly Relevant Here

Pesona Jiwa works with one guest at a time.

For this type of nervous-system work, I think that is significant.

The person does not need to:

Compare.

Perform.

Listen to other people’s trauma.

Adjust to group dynamics.

Wait for their turn.

Follow a generic timetable because everyone else is following it.

We can observe their responses.

Adjust.

Slow down.

Increase therapeutic work when appropriate.

Reduce intensity when necessary.

This makes taVNS integration much more individual.

It does not become:

“This is the protocol everyone receives.”

It becomes:

“What is happening with this person?”

Why Continuing at Home Matters

An intensive retreat can create an important interruption.

But the nervous system ultimately has to return to ordinary life.

Work.

Relationships.

Responsibilities.

Uncertainty.

Stress.

The objective cannot be to regulate someone only while they are inside a private Bali environment.

That would simply create dependence on the retreat.

This is one reason guests in the programme continue with a Zenowell device after leaving.

The intention is continuity.

The person has already learned how the technology fits into their wider regulation work.

They have experienced it alongside psychotherapy.

They understand it as a support rather than as a rescue device.

They can then continue incorporating it into the practices and behavioural changes established during the programme.

Again:

The device does not replace those changes.

It accompanies them.

Integration After the Retreat Is the Real Test

The important questions after an intensive programme are not:

“Did you feel calm in Bali?”

Of course many people feel different when their entire environment changes.

The useful questions are:

Can you recognise activation earlier at home?

Can you use what you learned before reaching exhaustion?

Can you maintain boundaries?

Can you tolerate other people’s disappointment?

Can you recover after a difficult working day?

Can you remain emotionally available?

Can you continue sleeping?

Can you use taVNS without believing it is the only thing keeping you functional?

That is what sustainable nervous-system regulation looks like.

Is taVNS Safe?

Overall, current research suggests taVNS is generally well tolerated.

One of the largest safety reviews evaluated 177 studies involving 6,322 participants.

The most commonly reported adverse effects included:

• ear discomfort or pain
• headache
• tingling

The review found no evidence of a causal relationship between taVNS and severe adverse events, although it also noted an important limitation: adverse-event reporting was inconsistent and many studies did not clearly report whether adverse events occurred.

More recent reviews continue to describe the treatment as generally well tolerated, with reported effects usually mild and transient, while emphasising the need for better standardised safety reporting.

That is reassuring.

But I do not think the phrase “generally safe” should be interpreted as:

“No assessment is required.”

Common Side Effects

Reported effects in the literature include things such as:

Tingling.

Local discomfort.

Ear pain.

Skin irritation.

Headache.

Occasionally dizziness, nausea or fatigue have also been described.

These effects are generally reported as mild and transient in the existing literature.

The person should still communicate what they are experiencing.

There is no therapeutic value in quietly enduring pain because somebody assumes discomfort means the device is working.

Who Should Be Cautious?

This is an area where device-specific instructions and individual medical assessment matter.

taVNS studies do not all use identical exclusion criteria, and there is not one universal contraindication list that can simply be applied to every device and every protocol.

That is why I would not create a definitive internet checklist and tell readers:

“If none of these apply to you, taVNS is safe.”

That would be irresponsible.

People with significant cardiovascular conditions, implanted electronic devices, neurological or medical complexity, pregnancy or other situations in which electrical stimulation may require additional consideration should discuss suitability with an appropriately qualified healthcare professional and follow the specific device manufacturer’s safety guidance.

The same applies if somebody experiences unexpected symptoms during stimulation.

Stop.

Assess.

Do not simply push through because the intervention is described online as safe.

Why Screening Matters at Pesona Jiwa

Within a clinical programme, the device should never be considered in isolation.

We want to know about:

Medical history.

Medication.

Psychiatric history.

Current symptoms.

Sleep.

Substance use.

Physical health.

Previous treatment.

The person’s reason for seeking support.

This matters because an exhausted person may assume they have “nervous system dysregulation” when the symptoms may also warrant medical investigation.

Fatigue can have many causes.

Palpitations can have many causes.

Dizziness can have many causes.

Sleep disturbance can have many causes.

Good nervous-system care should not encourage people to interpret every symptom through the vagus nerve.

taVNS Is Not Emergency Treatment

taVNS is not an alternative to urgent medical or psychiatric care.

Someone experiencing acute medical instability, severe psychiatric deterioration or immediate risk needs the appropriate level of assessment and treatment.

A nervous-system device should not become a way of trying to self-manage something requiring urgent professional care.

That sounds obvious.

But the more consumer neuromodulation grows, the more important it becomes to say.

Should Everyone Use taVNS?

No.

I do not think everyone needs taVNS.

Many people can improve nervous-system regulation through:

Sleep.

Psychotherapy.

Movement.

Relationships.

Reduced stress.

Boundaries.

Behavioural change.

The fact that a technology exists does not mean everyone needs it.

The relevant question is:

What is this person struggling with?

What have they already tried?

What is maintaining the problem?

Where might physiological support add something useful?

That is a clinical conversation.

When taVNS Becomes Most Interesting to Me

I become particularly interested when someone says:

“I understand all of this, but my body still reacts.”

They have insight.

They know their history.

They understand their patterns.

They may have been in therapy.

But there is still a strong physiological component.

They become overwhelmed quickly.

Cannot switch off.

Struggle to remain present when difficult material is approached.

Their system appears to move faster than their conscious understanding.

That is where taVNS may offer something useful.

Not a replacement for insight.

Potentially a bridge between insight and embodied experience.

What taVNS Cannot Do

It cannot make an abusive relationship healthy.

It cannot make chronic overwork sustainable.

It cannot create boundaries on your behalf.

It cannot process grief for you.

It cannot remove responsibility for behavioural change.

It cannot create trust where none exists.

It cannot repair sleep if you continue living in a way that makes restorative sleep almost impossible.

And it cannot replace the therapeutic relationship.

I think saying what an intervention cannot do is just as important as explaining what it may be able to support.

What taVNS May Add

Where it becomes interesting is as another input.

A physiological support.

Something that may reduce activation.

May support sleep.

May increase availability for psychotherapy.

May help some people remain more present.

May support a broader process of nervous-system regulation.

Those are possibilities worth exploring.

And in my own clinical work, particularly when using Zenowell alongside psychotherapy, I am seeing enough consistency in the changes I observe to believe this deserves much more serious research.

Not hype.

Research.

That is the distinction I want Pesona Jiwa to maintain.

The Real Aim Is Not Dependence on Technology

Ultimately, I do not want somebody leaving our programme believing:

“I can only regulate if my device is switched on.”

That would be the opposite of what we are trying to achieve.

I want them to leave understanding:

Their nervous system.

Their patterns.

Their triggers.

Their boundaries.

Their relationships.

Their early warning signs.

What helps them recover.

And where taVNS can sit within that picture.

The technology should increase options.

Not become the only option.

Because the goal has never been perfect calm.

The goal is greater capacity.

More flexibility.

More choice.

And a nervous system that is increasingly able to meet life without spending every day preparing to survive it.

How Long Does taVNS Take to Work?

This is one of the questions I am asked most often.

And I understand why.

When somebody has been struggling for months or years, they want to know when they should expect something to change.

After one session?

A week?

A month?

The problem is that there is no single answer.

Different taVNS studies use very different treatment schedules.

Some investigate what happens during or immediately after one session.

Others use daily stimulation for several weeks.

Some measure changes in symptoms.

Others look at sleep.

Cognition.

Physiology.

Brain activity.

This makes it impossible to say:

“taVNS takes exactly this long to work.”

What we can say is that immediate state changes and longer-term therapeutic change are not the same thing.

Some people notice something very quickly.

I see this clinically myself.

But a person feeling calmer during one session does not necessarily mean that a long-standing nervous-system pattern has fundamentally changed.

That distinction is important.

Immediate Effects Versus Longer-Term Change

There are really two different questions.

The first is:

Can taVNS produce an immediate experience?

For some people, apparently yes.

They may feel:

Calmer.

More grounded.

Less internally restless.

More present.

Less overwhelmed.

In my own psychotherapy work, I sometimes notice that change relatively quickly when Zenowell stimulation is introduced.

The second question is:

Can repeated use contribute to longer-term change?

That is much harder to answer.

And it is where repetition becomes important.

Many clinical studies that have reported improvements in symptoms have used repeated stimulation over weeks rather than relying on one session.

For example, controlled studies of taVNS for chronic insomnia have used repeated treatment over several weeks rather than treating one exposure as curative.

That fits with the way I think about nervous-system recovery more generally.

Long-standing patterns rarely develop in one day.

And they rarely disappear because of one intervention.

The Nervous System Learns Through Repetition

If you have spent years experiencing:

Stress.

Hypervigilance.

Poor sleep.

Overwork.

Fear.

Trauma.

Relational instability.

The nervous system has received thousands of repetitions.

Thousands of moments saying:

Stay alert.

Keep going.

Do not relax.

Do not trust this.

Something may go wrong.

You need to remain in control.

One calm experience is useful.

But it is competing with years of learning.

The system needs new evidence.

Repeatedly.

I can activate and recover.

I can rest and remain safe.

I can talk about this memory without being consumed by it.

I can allow somebody else to help.

I can set a boundary without losing the relationship.

This is one reason I resist the idea of a nervous-system “reset.”

Reset implies returning something instantly to its original state.

Human beings do not work like electronic equipment.

The nervous system learns.

And it can learn again.

Is There a Point Where You Should Feel Something?

I would also be cautious about expecting a dramatic sensation.

Some people assume that if taVNS is working they should immediately feel profoundly different.

That is not necessarily true.

The therapeutic effect of an intervention does not always correspond with how dramatic it feels.

And chasing sensation can create its own problems.

The person starts increasing intensity.

Monitoring constantly.

Asking:

“Do I feel different yet?”

They turn regulation into another performance task.

That is exactly what many people coming to Pesona Jiwa are already doing in other parts of their lives.

I would rather observe broader patterns.

How are you sleeping?

How quickly are you recovering after stress?

Are you more emotionally available?

What happens during therapy?

Can you tolerate difficult material differently?

Are you less reactive?

Are you more present?

Those changes tell me far more than whether the ear stimulation felt strong.

Can You Use taVNS Every Day?

Daily stimulation is used in a number of published research protocols.

But again, that should not be translated into:

“Everyone should use taVNS every day.”

The appropriate frequency depends on:

The device.

The stimulation parameters.

The individual.

Their health history.

The reason it is being used.

How they respond.

And the specific safety instructions associated with the technology.

Within our 28-Day taVNS Intensive, repeated use sits inside an observed and structured programme.

We are not simply giving someone a device and telling them to stimulate as often as possible.

We watch what happens.

How they respond.

How therapy changes.

How sleep changes.

Whether the person feels overstimulated.

Whether the intervention remains useful.

That is a fundamentally different approach from chasing dosage.

More Is Not Necessarily Better

This principle deserves repeating.

People who are high performing often approach treatment competitively.

If thirty minutes is good, sixty must be better.

If this intensity produces a sensation, a higher intensity must produce a greater effect.

That assumption is not justified.

Neuromodulation is not weightlifting.

There is no reason to believe the person who tolerates the highest stimulation is receiving the best therapeutic effect.

Good treatment is not about enduring as much as possible.

It is about using the intervention appropriately.

Can You Overuse taVNS?

There is still much to learn about optimal treatment schedules.

Existing research generally suggests that taVNS is well tolerated, but the absence of a universally accepted protocol is exactly why I would avoid treating it casually.

If a person experiences persistent discomfort or unexpected symptoms, the answer is not:

“Push through.”

Stop.

Reassess.

Follow the manufacturer’s guidance.

Seek clinical advice where appropriate.

A nervous-system intervention should never become another opportunity to override the body.

Does taVNS Increase Vagal Tone?

This is one of the most common claims made online.

“taVNS increases vagal tone.”

It sounds scientific.

The reality is more complicated.

The phrase vagal tone is often used loosely.

Frequently, people are referring to heart-rate variability, or HRV.

But HRV is not a direct measurement of the entire vagus nerve.

It is influenced by:

Breathing.

Age.

Fitness.

Medication.

Sleep.

Posture.

Time of day.

Alcohol.

Illness.

Measurement technique.

Stress.

And many other factors.

Some taVNS studies have investigated HRV and other autonomic measures.

Results are mixed.

That does not mean taVNS has no autonomic effect.

It means we should not treat one wearable measurement as proof that somebody has successfully “toned” their vagus nerve.

Can You Strengthen the Vagus Nerve?

I am also cautious with the language of “strengthening” the vagus nerve.

The vagus nerve is not a muscle.

We are not doing vagus nerve repetitions until it becomes stronger.

When people use that language, what they often actually mean is:

Can I improve autonomic flexibility?

Can I recover from stress more effectively?

Can I improve my ability to transition between activation and rest?

Those are much better questions.

And they bring us back to the central theme of this entire guide.

The goal is not a stronger vagus nerve.

The goal is greater nervous-system capacity.

taVNS Versus Implanted Vagus Nerve Stimulation

These interventions are often spoken about as if they are the same thing.

They are not.

Implanted VNS involves surgery.

A pulse generator is implanted and connected to the cervical vagus nerve.

It has established medical applications, including particular cases of epilepsy and treatment-resistant depression.

taVNS is non-invasive.

Stimulation is applied through areas of the external ear associated with auricular vagal innervation.

No implanted generator.

No surgical lead around the cervical vagus nerve.

That makes taVNS considerably easier to use and study.

But we cannot simply take everything we know about implanted VNS and assume taVNS will produce identical effects.

They stimulate the system differently.

They have different evidence bases.

And they have different regulatory histories.

taVNS Versus “Vagus Nerve Exercises”

This is another important distinction.

Online nervous-system content often places all vagus nerve interventions into the same category.

Humming.

Singing.

Gargling.

Slow breathing.

Cold water.

Massage.

taVNS.

But these are not equivalent interventions.

A slow breathing practice may influence autonomic state through respiratory and cardiovascular pathways.

Singing may combine respiration, vocalisation and social engagement.

Cold exposure creates a strong physiological stress response.

taVNS delivers controlled electrical stimulation through an auricular target.

They may all influence aspects of physiology.

That does not mean they are doing the same thing.

Are Vagus Nerve Exercises Useless?

No.

I do not think that at all.

Some simple practices are extremely useful.

Slow breathing.

Movement.

Safe connection.

Singing.

Meditation for people who tolerate it.

Time in nature.

These can support regulation.

The mistake is claiming that every benefit occurs because somebody has specifically “activated the vagus nerve.”

Sometimes a useful practice is simply useful.

We do not need to exaggerate the mechanism.

Why taVNS Is Different

The key difference is that taVNS is an electrical neuromodulation technique.

We are deliberately applying stimulation to anatomical areas selected because of their relationship with auricular vagal pathways.

That makes it fundamentally different from general lifestyle practices.

It is also why we need higher standards when talking about evidence.

The more medical or technological an intervention becomes, the more precise we should be about what is known.

Can taVNS Permanently Regulate the Nervous System?

I would not use that language.

There is no point at which a human nervous system becomes permanently regulated.

Life changes.

Stress changes.

Relationships change.

Health changes.

Loss occurs.

Trauma can occur.

The nervous system will continue responding.

The goal is not permanent regulation.

The goal is greater flexibility.

And even if repeated taVNS ultimately proves useful for increasing that flexibility in particular populations, lasting change will still depend on the context in which somebody lives.

This is why the rest of the work matters.

If Nothing Else Changes, Old Patterns Can Return

Imagine somebody spends 28 days becoming calmer.

Sleeping.

Using taVNS.

Attending therapy.

Eating well.

Living somewhere quiet.

Then they return to:

Fourteen-hour working days.

No boundaries.

Poor sleep.

Chronic conflict.

Constant notifications.

Heavy alcohol use.

No support.

It would be unrealistic to expect any nervous-system intervention to compensate indefinitely.

This is why I keep returning to the same question:

What keeps activating the nervous system?

Regulation cannot simply become a technique for tolerating an intolerable life.

Sometimes the life needs to change.

taVNS Should Create More Choice, Not More Tolerance for Harm

This is particularly important in trauma work.

We do not want someone becoming better regulated simply so they can tolerate an abusive relationship more effectively.

We want greater regulation to increase clarity.

Agency.

Choice.

The ability to recognise:

This is not okay.

I need a boundary.

I need support.

I need to leave.

Regulation should not make someone more compliant with harmful conditions.

It should make them more able to respond deliberately.

Can You Become Dependent on taVNS?

Not in the way we normally use the term physiological dependence for drugs.

But psychologically, I think people can become overly dependent on almost any regulation strategy.

A device.

A therapist.

Meditation.

Exercise.

A specific routine.

The concern becomes:

“I cannot cope unless I have this.”

That is not what I want.

The Zenowell device should become one of several resources.

Not the entire regulation system.

The person should also develop:

Awareness.

Boundaries.

Relational support.

Body awareness.

Sleep routines.

Emotional capacity.

Behavioural flexibility.

Psychotherapeutic understanding.

Then taVNS has a place within something much larger.

Why We Send the Zenowell Device Home

There is an important reason the guest takes the device with them after the programme.

The retreat is not the real world.

It creates an interruption.

A controlled environment.

Space.

The person then returns to ordinary life.

That is where nervous-system learning has to continue.

Having access to the same Zenowell technology they used during the 28-day programme creates continuity.

It is familiar.

They understand how it feels.

They understand where it fits.

They are not suddenly experimenting with something new after returning home.

But the device goes home alongside the psychological work.

Not instead of it.

What Does Success Look Like?

If I am assessing whether our nervous-system work has been useful, I am not primarily interested in whether somebody says:

“The device relaxes me.”

I want to know:

Are you sleeping?

How are your relationships?

Are you reacting differently?

Can you recognise activation earlier?

What happens when somebody disagrees with you?

Are you still drinking every night to switch off?

Can you leave work?

Can you tolerate doing nothing?

Can you allow another person to help?

Can you talk about what happened without disappearing back into it?

These are meaningful outcomes.

What Regulation Actually Looks Like

Regulation rarely feels dramatic.

It often looks like:

You recover more quickly after a difficult conversation.

You notice yourself beginning to overthink and stop earlier.

You sleep after a stressful day instead of remaining alert all night.

You disagree with somebody without feeling that the relationship is ending.

You remember something painful without becoming completely consumed by it.

You realise you are exhausted and rest.

You feel anger and set a boundary.

You ask someone for help.

You enjoy something without immediately thinking about what comes next.

These are small things.

And they are enormous things.

Can taVNS “Reset” Your Nervous System?

I would avoid the word reset.

It is useful marketing.

I do not think it is useful clinical language.

There is no factory setting we are trying to return somebody to.

Their nervous system developed through experience.

Their history matters.

Their relationships matter.

Their personality matters.

Their culture matters.

Their life matters.

Recovery is not erasing that history.

It is adding new information.

New responses.

New capacity.

I prefer the word recalibration if we need one.

But even that should not suggest a single event.

It is a process.

Why Neuroplasticity Matters

This is where neuroplasticity becomes relevant.

The nervous system is capable of change.

Repeated experience can alter how we respond.

This is one of the fundamental reasons psychotherapy works.

Why habits change.

Why exposure can change fear responses.

Why relationships can change expectations.

Why recovery remains possible after years of difficulty.

taVNS may ultimately prove useful partly because neuromodulation occurs within a nervous system that is already capable of learning.

But stimulation alone is not the learning.

What happens while the system is in that state may matter enormously.

This is one of the reasons I am particularly interested in using Zenowell during psychotherapy.

Neuromodulation Plus Experience

If somebody receives stimulation while:

Feeling connected.

Exploring an old memory.

Remaining present.

Making sense of an experience.

Recognising a pattern.

Practising a new response.

Then the neuromodulation is occurring within a meaningful psychological context.

This is one area where I think future research could become particularly interesting.

Is taVNS more effective for some psychological outcomes when paired with particular forms of learning or psychotherapy?

Does timing matter?

Does the state the person is in during stimulation matter?

Does concurrent therapeutic engagement change the outcome?

These questions are much more interesting to me than asking whether electricity itself “heals trauma.”

Frequently Asked Questions About taVNS

What is taVNS?

taVNS stands for transcutaneous auricular vagus nerve stimulation.

It is a non-invasive neuromodulation method that delivers mild electrical stimulation through specific areas of the external ear associated with sensory innervation from the auricular branch of the vagus nerve.

Is taVNS the same as implanted VNS?

No.

Traditional VNS involves surgically implanting a device connected to the cervical vagus nerve.

taVNS uses an external device and stimulates through the ear without surgery.

The two approaches have different evidence bases and should not be treated as identical.

Does taVNS hurt?

It generally should not be painful.

People commonly describe tingling, pulsing or mild electrical sensation.

Local discomfort can occur.

There is no therapeutic benefit in deliberately pushing stimulation to painful levels.

Is taVNS safe?

Published research generally describes taVNS as well tolerated, with most reported adverse effects being mild and temporary.

However, safety screening, device instructions and individual medical circumstances remain important.

Who should not use taVNS?

There is no one universal exclusion list covering every device and every protocol.

People with significant medical conditions, implanted electronic devices, pregnancy or other relevant health considerations should obtain appropriate professional advice and follow the manufacturer’s specific guidance.

How quickly does taVNS work?

Some people notice subjective changes during or shortly after stimulation.

Longer-term effects are more difficult to define and studies often use repeated stimulation over several weeks.

Immediate calm should not be confused with permanent nervous-system change.

Can I use taVNS every day?

Daily use appears in multiple research protocols, but the appropriate schedule depends on the device, the person and the purpose for which it is being used.

More stimulation is not automatically better.

How long is a taVNS session?

Research protocols vary considerably.

Some use short laboratory sessions, while clinical studies often use repeated sessions of approximately 30 minutes or longer.

There is currently no universally established ideal session length across all applications.

Does taVNS increase vagal tone?

Research has examined autonomic measures such as heart-rate variability, but results vary.

HRV itself is influenced by many factors and should not be treated as a direct universal measurement of “vagus nerve strength.”

Does taVNS stimulate the parasympathetic nervous system?

taVNS engages sensory pathways associated with the vagus nerve and may influence wider autonomic and central nervous-system networks.

Describing it simply as “switching on the parasympathetic nervous system” is an oversimplification.

Does taVNS regulate the nervous system?

It is being investigated for its effects on autonomic and central nervous-system processes.

Some people report subjective improvements in regulation.

However, nervous-system regulation depends on far more than electrical stimulation alone.

Can taVNS help anxiety?

There is emerging research investigating taVNS and anxiety.

Evidence is developing rather than definitive.

Anxiety has psychological, physiological and environmental components, so taVNS should not be considered a universal standalone treatment.

Can taVNS help depression?

Depression is one of the more extensively studied psychiatric applications of taVNS.

Meta-analyses have reported encouraging findings, but study quality and protocol differences mean further high-quality research is still needed.

Can taVNS help PTSD?

Early studies are examining this.

The evidence remains preliminary.

taVNS should not currently be described as a proven standalone PTSD treatment.

Can taVNS heal trauma?

I would not make that claim.

Trauma involves memory, relationship, attachment, identity, beliefs, emotions and physiological responses.

taVNS may potentially support regulation while trauma is being addressed therapeutically, but it does not replace trauma therapy.

Can taVNS support psychotherapy?

This is one of the areas I am particularly interested in clinically.

In my own work using Zenowell during psychotherapy, I frequently observe clients appearing calmer, opening up more quickly and being better able to explore difficult experiences while remaining present.

These are my clinical observations, not controlled research findings.

Formal research is needed to determine whether and how concurrent taVNS may enhance psychotherapeutic engagement.

Can taVNS help sleep?

The sleep evidence is increasingly interesting.

Randomised controlled trials and a recent meta-analysis have reported improvements in insomnia measures, although the overall certainty of evidence is still limited and larger studies are required.

Can taVNS help burnout?

Direct burnout-specific research remains early.

There are emerging studies examining areas relevant to burnout, including cognition, stress and autonomic functioning, but taVNS should not currently be presented as a proven burnout treatment.

Does taVNS work for everyone?

No intervention works identically for everyone.

Response can vary considerably.

Is Zenowell the treatment used at Pesona Jiwa?

Zenowell technology is the taVNS technology integrated into our programme.

It is one component of the broader Pesona Jiwa approach.

The treatment environment also includes psychotherapy, Polyvagal-informed work, nervous-system education, movement, restorative practices, nutrition, sleep support and private one-to-one care.

Why is the Pesona Jiwa taVNS programme 28 days?

The 28-Day taVNS Intensive is Pesona Jiwa’s clinical programme design.

Twenty-eight days is not claimed as a universally proven taVNS treatment duration.

It allows enough time for repeated stimulation to be integrated alongside psychotherapy, behavioural work, sleep, nervous-system education and the development of sustainable recovery practices.

Do guests keep the device?

Yes.

Guests completing the dedicated programme take the Zenowell device with them so they can continue incorporating the technology into the nervous-system practices developed during their stay.

Can taVNS replace therapy?

No.

I do not regard it as a replacement for psychotherapy.

In our work, its most interesting role may actually be alongside therapy.

Can taVNS permanently reset the nervous system?

I would not use that language.

The nervous system remains responsive throughout life.

The goal is not permanent calm.

It is greater flexibility, improved recovery and increased capacity.

Key Takeaways

• taVNS stands for transcutaneous auricular vagus nerve stimulation.
• It uses mild electrical stimulation applied through the external ear.
• It differs substantially from surgically implanted vagus nerve stimulation.
• The auricular branch of the vagus nerve provides a non-invasive route for accessing vagal sensory pathways.
• A large proportion of vagal signalling travels towards the brain.
• taVNS is better understood as neuromodulation than as simply “switching on calm.”
• The vagus nerve is important but should not be treated as the entire nervous system.
• The tragus and conchal areas are commonly investigated stimulation targets.
• There is still no single universally accepted optimal taVNS protocol.
• Frequency, pulse width, intensity, placement and duration all vary across studies.
• Stronger stimulation does not automatically mean better stimulation.
• Immediate subjective effects and long-term nervous-system change are different outcomes.
• Depression has one of the more developed taVNS research bases.
• Sleep research is increasingly encouraging.
• Anxiety research is developing.
• PTSD research remains preliminary.
• Direct burnout research remains early.
• taVNS is being investigated in pain, cognition, inflammatory processes and other areas.
• Being researched for a condition does not mean taVNS is an established treatment for that condition.
• Published safety evidence is generally reassuring.
• Most reported adverse effects are mild and temporary.
• Individual screening and device-specific safety guidance still matter.
• taVNS is not a replacement for urgent medical or psychiatric treatment.
• taVNS does not replace psychotherapy.
• It does not make an unsafe environment safe.
• It cannot create boundaries or behavioural change for someone.
• In my clinical work, Zenowell taVNS used during psychotherapy frequently appears to produce a rapid settling of nervous-system activation.
• I often observe people becoming more open and able to explore difficult experiences more matter-of-factly.
• Some seem able to view traumatic experiences from what I describe as a “helicopter view,” remaining connected to the memory without being as fully re-immersed in it.
• These are clinical observations, not research findings.
• The relationship between concurrent taVNS and psychotherapy deserves formal study.
• The Pesona Jiwa intensive is 28 days.
• Twenty-eight days is our clinical programme model, not a scientifically established universal taVNS duration.
• Guests use Zenowell technology within a much broader therapeutic environment.
• They take the device home to support continuity after the programme.
• Long-term nervous-system recovery requires more than a device.
• Sustainable regulation involves sleep, relationships, environment, boundaries, psychotherapy, behaviour and repeated experiences of safety.
• The ultimate goal is not permanent calm.
• The goal is greater capacity.

Article Summary

Transcutaneous auricular vagus nerve stimulation, or taVNS, is emerging as one of the more interesting areas within modern neuromodulation and nervous-system research.

It involves delivering mild electrical stimulation through areas of the external ear associated with sensory innervation from the auricular branch of the vagus nerve.

Unlike traditional implanted vagus nerve stimulation, taVNS does not require surgery.

That accessibility has allowed researchers to investigate it across a wide range of areas.

Depression.

Anxiety.

Sleep.

PTSD.

Stress.

Burnout.

Pain.

Cognition.

Inflammation.

But interest should not be confused with established evidence.

The quality and maturity of research differs considerably between these areas.

Depression has a meaningful but still developing evidence base.

Research into insomnia has produced increasingly encouraging results.

Anxiety studies are emerging.

PTSD research remains early.

Direct burnout evidence remains extremely limited.

taVNS therefore sits in an interesting position.

There is enough evidence to take it seriously.

There is not enough evidence to treat it as a universal nervous-system treatment.

The mechanism is also more complex than popular descriptions suggest.

The vagus nerve is not simply a calming switch.

A large proportion of vagal fibres carry sensory information towards the brain.

Auricular stimulation may therefore influence brainstem and wider neural networks involved in autonomic regulation, arousal, attention, mood and other processes.

Research frequently discusses pathways involving the nucleus tractus solitarius and other connected brain regions.

But the exact mechanisms remain under investigation.

Protocols also vary enormously.

Researchers use different stimulation sites, frequencies, pulse widths, intensities, treatment durations and devices.

There is no single scientifically established “best taVNS protocol.”

At Pesona Jiwa, this uncertainty is important.

We do not present taVNS as a cure.

We integrate Zenowell technology within a much broader nervous-system and psychotherapeutic programme.

The most interesting part for me has been what I observe when taVNS is used during psychotherapy.

In almost all of the cases where I have used Zenowell in this way, I notice what appears to be a rapid settling of nervous-system activation.

People often seem to open up more quickly.

They become more able to approach difficult and traumatic experiences.

The experience sometimes appears more matter-of-fact.

The memory is still there.

The event remains significant.

But its immediate emotional and physiological impact appears reduced.

I often describe this as a helicopter view.

The person can see what happened.

They can examine it.

But they do not appear quite as immersed inside it.

That can make reflection easier.

Patterns become visible.

Answers become more accessible.

The person may be able to understand the causes and conditions behind behaviours without becoming overwhelmed by the experience they are examining.

These are my clinical observations.

They are not research findings.

I am not claiming that taVNS prevents retraumatisation or treats trauma.

But I am seeing the pattern consistently enough to believe the relationship between taVNS and psychotherapy deserves formal investigation.

This is also why we use taVNS as an integrated intervention rather than a standalone treatment.

The technology sits alongside:

Psychotherapy.

Polyvagal-informed practice.

Nervous-system education.

Sleep.

Movement.

Bodywork.

Meditation and mindfulness.

Nutrition.

Nature.

Private space.

And behavioural change.

Our dedicated programme runs for 28 days.

That duration is a Pesona Jiwa clinical model.

It is not based on a claim that research has established 28 days as the universal taVNS treatment period.

The duration provides time for repeated stimulation, but equally importantly, it provides time for nervous-system patterns to become visible and for new experiences to be repeated.

The guest eventually takes the Zenowell device home.

That provides continuity.

But the objective is never dependence on the device.

The person should leave understanding themselves more deeply.

Their triggers.

Their patterns.

Their limits.

Their relationships.

Their boundaries.

Their need for recovery.

Where the technology helps.

And where something in their life needs to change.

Because nervous-system regulation is not about attaching a device to the ear and becoming permanently calm.

It is about developing the capacity to experience life without becoming permanently trapped in survival.

taVNS may prove to be a valuable tool in that process.

But the tool should always serve the person.

Not replace them.

External Evidence and Research References

The evidence used throughout this guide comes primarily from peer-reviewed systematic reviews, meta-analyses, randomised controlled trials and neuroanatomical or neuroimaging studies.

Where the evidence remains preliminary, I have tried to make that clear rather than presenting emerging findings as established clinical fact.

taVNS Clinical Applications and Stimulation Parameters

A 2024 scoping review examined 109 studies across 21 different clinical populations and explored therapeutic applications, stimulation parameters, sham protocols and safety.

The review found substantial variation in stimulation site, frequency, intensity, pulse width and treatment duration, which is one of the reasons there is currently no single universally accepted taVNS protocol.

Clinical application of transcutaneous auricular vagus nerve stimulation: a scoping review — PubMed

This is one of the most useful overview papers for understanding both the breadth of taVNS research and the current problem of protocol standardisation.

taVNS Safety — More Than 6,000 Participants

One of the largest systematic safety reviews analysed 177 studies involving 6,322 participants.

The most frequently reported adverse effects were ear pain, headache and tingling. The review did not identify a causal relationship between taVNS and severe adverse events, although the authors also highlighted inconsistent reporting of adverse events across the literature.

Safety of transcutaneous auricular vagus nerve stimulation: a systematic review and meta-analysis — PubMed

This is the primary safety reference I would use wherever the article discusses tolerability or adverse effects.

taVNS and Depression — Systematic Review and Meta-Analysis

A 2023 systematic review and meta-analysis included 12 studies with 838 participants experiencing depressive disorders.

The pooled results suggested improvements in depression scores, but the authors rated important parts of the evidence as low to very low quality and noted that several subgroups contained only small numbers of studies.

The efficacy and safety of transcutaneous auricular vagus nerve stimulation in depressive disorder — PubMed

This supports describing depression findings as encouraging rather than definitive.

taVNS, Depression, Neural Connectivity and Inflammation

A separate systematic review examined clinical, neural and anti-inflammatory findings in major depressive disorder.

Only five clinical studies specifically evaluated patients with depression, and the researchers concluded that the available human clinical evidence remained too heterogeneous and limited for firm conclusions.

The review is particularly useful because it distinguishes human evidence from animal research around inflammatory mechanisms.

Neural, Anti-Inflammatory, and Clinical Effects of Transauricular Vagus Nerve Stimulation in Major Depressive Disorder — PubMed

taVNS for Chronic Insomnia — Randomised Clinical Trial

A 2024 randomised clinical trial published in JAMA Network Open studied people with chronic insomnia disorder.

Participants received active or sham taVNS for 30 minutes twice daily, five days per week for eight weeks, followed by a 12-week follow-up.

The active group demonstrated greater improvement in sleep quality compared with sham treatment.

Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Insomnia Disorder: A Randomized Clinical Trial — PubMed

This is one of the strongest primary clinical studies we currently reference for sleep.

Second Randomised taVNS Trial for Chronic Insomnia

A 2025 double-blind randomised sham-controlled trial included 40 people with chronic insomnia disorder.

Participants received 30 minutes of active or sham taVNS daily for six weeks, with the study reporting improvements in sleep quality in the active group.

taVNS improves sleep quality in chronic insomnia disorder: double-blind randomized sham-controlled trial — PubMed

taVNS for Insomnia — Systematic Review and Meta-Analysis

A 2025 systematic review and meta-analysis included six studies and 336 patients.

The pooled analysis found improvements in sleep quality and insomnia severity. Importantly, however, the certainty of evidence was rated low for sleep quality and very low for insomnia severity, so the findings should still be described as promising rather than settled.

Transcutaneous Auricular Vagus Nerve Stimulation in Insomnia: A Systematic Review and Meta-Analysis — PubMed

A newer 2026 meta-analysis covering 14 randomised trials also reported improvements in sleep-related outcomes while cautioning that heterogeneity and limited clinical interpretability mean the evidence should still be considered preliminary.

taVNS for sleep disorders: systematic review and meta-analysis — PubMed

taVNS and Anxiety — Randomised Controlled Trial

A 2024 double-blind randomised controlled trial investigated taVNS in university students with elevated anxiety.

The study examined anxiety alongside masseter muscle activity and pain measures and found changes following active stimulation compared with sham.

Transcutaneous auricular vagus nerve stimulation modulates anxiety levels in university students — PubMed

This is useful evidence that anxiety-related outcomes are being investigated clinically, but it should not be presented as evidence that taVNS is an established treatment for anxiety disorders generally.

taVNS and PTSD — Randomised Feasibility Study

A recent double-blind sham-controlled feasibility study involved 32 World Trade Center responders with PTSD.

Participants used active or sham taVNS for 15 minutes daily over eight weeks.

Forty per cent of those receiving active stimulation achieved a 10-point reduction on clinician-rated PTSD symptoms compared with 28.5% in the sham group, but significant differences were not seen across all self-reported outcomes.

The authors described the intervention as feasible and acceptable and called for larger studies.

Effects of taVNS on PTSD Symptoms in World Trade Center Responders — PubMed

This supports our existing position that the PTSD evidence is interesting but still preliminary.

taVNS Combined With Slow Breathing in Trauma-Related Symptoms

A 2026 pilot study examined expiratory-gated taVNS combined with slow breathing in people experiencing war-related traumatic stress.

Because this was a pilot study rather than definitive efficacy research, it is most useful as evidence that researchers are actively investigating combined physiological and therapeutic/regulation approaches rather than taVNS only as an isolated intervention.

Expiratory-Gated taVNS Combined With Slow Breathing in War-Related Traumatic Stress — PubMed

Early Research Into taVNS and Occupational Burnout

Direct burnout-specific evidence is still extremely limited.

A 2025 study investigated the immediate effects of transcutaneous vagus nerve stimulation on executive-function-related neural processing in 27 participants with occupational burnout and 24 participants without burnout.

The results suggested that stimulation altered some neural processing measures, but behavioural executive-function benefits were clearer in participants without burnout.

The researchers therefore treated the findings cautiously rather than claiming a burnout treatment effect.

Exploring the impact of transcutaneous vagus nerve stimulation in subjects with and without burnout — PubMed

This is currently the best direct source for supporting the statement that taVNS is being investigated in burnout, while making clear that evidence is still very early.

Anatomical Basis of Auricular Vagus Nerve Stimulation

One of the strongest foundational anatomical reviews examines the auricular branch of the vagus nerve, its distribution within the external ear, and evidence from cadaveric, electrophysiological, neuroimaging and autonomic studies.

It also explains why auricular anatomy is more complicated than simply saying that every area of the ear is “the vagus nerve.”

The anatomical basis for transcutaneous auricular vagus nerve stimulation — PMC

This is the key source I would retain for sections discussing:

• the auricular branch of the vagus nerve
• ear stimulation sites
• the tragus
• the cymba conchae
• overlapping sensory innervation
• brainstem pathways
• the nucleus tractus solitarius

Neuroimaging Evidence and the Brain Networks Engaged by taVNS

A concurrent taVNS/fMRI study examined electrical stimulation of the tragus.

Active stimulation produced changes across several cortical and subcortical regions, and the authors concluded that tragus stimulation appeared capable of engaging cerebral afferent vagal pathways.

They also emphasised that future research should systematically examine stimulation parameters and alternative targets.

Neurophysiologic effects of taVNS via electrical stimulation of the tragus: concurrent taVNS/fMRI study and review — PMC

This is particularly useful in the sections explaining why taVNS should be thought of as neuromodulation involving distributed networks, rather than as a simple switch that “turns on the parasympathetic nervous system.”

About the Author

Matt Little, M.A., Dip Couns, MBACP, AP APM, ICAP I, PVI Certified, is a psychotherapist, addiction specialist and Clinical Director of Pesona Jiwa in Bali, Indonesia.

With more than 15 years of experience in counselling, psychotherapy, addiction treatment, trauma recovery and nervous-system regulation, Matt works with individuals experiencing trauma, chronic stress, burnout, anxiety, addiction, emotional numbness and nervous-system dysregulation.

He holds a Master’s Degree with Distinction in Counselling & Psychotherapy Practice and is a registered member of the British Association for Counselling and Psychotherapy.

Matt is also an International Certified Addiction Professional, an Advanced Practitioner Member of Addiction Professionals and a Polyvagal-Informed Practitioner through the Polyvagal Institute under the work of Dr Stephen Porges.

His clinical approach integrates Person-Centred Psychotherapy with trauma-informed practice, addiction recovery, attachment, behavioural change, autonomic nervous-system understanding and emerging physiological approaches to nervous-system support.

At Pesona Jiwa, Matt has integrated Zenowell taVNS technology into psychotherapy and the wider private retreat environment.

His interest is not in replacing psychotherapy with technology.

It is in exploring whether appropriately used physiological support can help some people become safe enough, present enough and regulated enough to engage more deeply with the therapeutic process.

Learn more about Matt Little and his clinical approach.

Brainz Magazine Executive Contributor

Elephant Journal

Published Articles:

• Why Rest Alone Does Not Fix Burnout
• Pesona JiwaBestWellnessRetreat2025
• Transform Your Life with Pesona Jiwa: Bali’s Exclusive Luxury Wellness Retreat
• When Burnout doesn’t look like Burnout, but a Quiet Loss of Self.
• The Moment I Realised my Nervous System wasn’t Broken—Just Exhausted.
  

  ---

  Explore Related Resources

  If you are interested in learning more about nervous system regulation, trauma recovery, burnout, addiction, and emotional wellbeing, you may find these resources helpful:

  Foundational Guides

  • Nervous System Regulation: A Complete Guide
  • The Window of Tolerance
  • Polyvagal Theory Explained
  • Nervous System Dysregulation Symptoms
  • Functional Freeze Symptoms

  Burnout and Chronic Stress

  • Burnout Recovery for High Performers
  • Why Rest Doesn’t Fix Burnout
  • Why High Achievers Can’t Switch Off
  • Emotional Exhaustion Symptoms
  • Why You Feel Fine Until You Stop
  • Luxury Burnout Retreat Bali – Why Privacy Matters
  • Why Do I Feel I’ve Lost Myself
  • Why Can’t I Relax Even When Nothing Is Wrong
  • When High Performers Start To Burnout
  • What’s the Best Burnout Retreat

  Emotional Numbness and Disconnection

  • Why High-Functioning People Become Emotionally Numb
  • Hidden Biology of Emotional Numbness
  • Why Chronic Stress Makes You Feel Disconnected
  • Why Your Nervous System Holds the Key to Emotional Balance
  • Why Do Successful People Feel Empty

  Addiction and Behaviour Change

  • High-Functioning Addiction Signs
  • Dopamine and Addiction
  • Why You Can’t Relax Without Alcohol
  • How to Regulate Your Nervous System Without Substances

  Trauma

  • What is Neuroplasticity
  • What is Complex Trauma
  • Why Therapy Alone Sometimes Isn’t Enough
  • What Is Neuroplasticity? How Your Brain Learns New Patterns and Why Recovery Is Always Possible
  • What is Emotional Regulation
  • How Childhood Trauma Shapes Adult relationships
  • Why Trauma Keeps You Stuck in Survival Mode
  • Why You Keep Attracting Emotionally Unavailable People
  • Why You Can’t Let Go of the Past

  Retreats and Programmes

  • Trauma Healing Retreat Bali
  • taVNS Intensive Healing Retreat Bali
  • The Sacred Soul Retreat Bali